Maria E. Suarez-Almazor, M.D., Ph.D.

Peer-Reviewed Articles

1. Bruera S, Lei X, Pundole X, Zhao H, Giordano SH, Vinod S, Suarez-Almazor ME. Systemic Lupus Erythematosus is a Risk Factor for Mortality in Elderly Patients with Early Breast Cancer. Arthritis Care Res (Hoboken) 75(3):559-568, 2023. e-Pub 2022. PMID: 34558796.
2. Kwakkenbos L, Østbø N, Carrier ME, Nielson WR, Fedoruk C, Levis B, Henry RS, Pope J, Frech T, Gholizadeh S, Johnson SR, Piotrowski P, Jewett LR, Gordon J, Chung L, Bilsker D, Tao L, Turner KA, Cumin J, Welling J, Fortuné C, Leite C, Gottesman K, Sauvé M, Reyna TSR, Hudson M, Larche M, van Breda W, Suarez-Almazor ME, Bartlett SJ, Malcarne VL, Mayes MD, Boutron I, Mouthon L, Benedetti A, Thombs BD, SPIN Investigators. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program. Pilot Feasibility Stud 8(1):45, 2022. e-Pub 2022. PMID: 35219340.
3. Lopez-Olivo MA, des Bordes JKA, Jibaja-Weiss M, Volk RJ, Suarez-Almazor ME. Preferred Strategies for Delivering Health Information to Patients With Musculoskeletal Disorders: A Qualitative Study. J Clin Rheumatol 28(1):e102-e109, 2022. e-Pub 2020. PMID: 33298811.
4. Manzano JM, Lin H, Zhao H, Halm J, Suarez-Almazor ME. Derivation and Validation of the Cancer READMIT Score: A Readmission Risk Scoring System for Patients With Solid Tumor Malignancies. JCO Oncol Pract 18(1):OP2001077, 2022. e-Pub 2021. PMID: 34357793.
5. Bruera S, Lei X, Zogala R, Pundole X, Zhao H, Giordano SH, Hwang JP, Rauh-Hain JA, Suarez-Almazor ME. Cervical Cancer Screening in Women with Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 73(12):1796-1803, 2021. e-Pub 2021. PMID: 32799430.
6. Santomasso BD, Nastoupil LJ, Adkins S, Lacchetti C, Schneider BJ, Anadkat M, Atkins MB, Brassil KJ, Caterino JM, Chau I, Davies MJ, Ernstoff MS, Fecher L, Funchain P, Jaiyesimi I, Mammen JS, Naidoo J, Naing A, Phillips T, Porter LD, Reichner CA, Seigel C, Song JM, Spira A, Suarez-Almazor ME, Swami U, Thompson JA, Vikas P, Wang Y, Weber JS, Bollin K, Ghosh M. Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline. J Clin Oncol 39(35):JCO2101992, 2021. e-Pub 2021. PMID: 34724386.
7. Schneider BJ, Naidoo J, Santomasso BD, Lacchetti C, Adkins S, Anadkat M, Atkins MB, Brassil KJ, Caterino JM, Chau I, Davies MJ, Ernstoff MS, Fecher L, Ghosh M, Jaiyesimi I, Mammen JS, Naing A, Nastoupil LJ, Phillips T, Porter LD, Reichner CA, Seigel C, Song JM, Spira A, Suarez-Almazor ME, Swami U, Thompson JA, Vikas P, Wang Y, Weber JS, Funchain P, Bollin K. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 39(36):JCO2101440, 2021. e-Pub 2021. PMID: 34724392.
8. Chanson N, Ramos-Casals M, Pundole X, Suijkerbuijk K, José de Barros E Silva M, Lidar M, Benesova K, Leipe J, Acar-Denizli N, Pradère P, Michot JM, Voisin AL, Suarez-Almazor ME, Radstake TRD, Fernandes Moça Trevisani V, Schulze-Koops H, Melin A, Robert C, Mariette X, Baughman RP, Lambotte O, ICIR, Coordination, Co-Convenors, Steering Committee, Research Fellows, Data Scientist. Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation. Eur J Cancer 158:208-216, 2021. e-Pub 2021. PMID: 34452793.
9. Nordlund J, Henry RS, Kwakkenbos L, Carrier ME, Levis B, Nielson WR, Bartlett SJ, Dyas L, Tao L, Fedoruk C, Nielsen K, Hudson M, Pope J, Frech T, Gholizadeh S, Johnson SR, Piotrowski P, Jewett LR, Gordon J, Chung L, Bilsker D, Levis AW, Turner KA, Cumin J, Welling J, Fortuné C, Leite C, Gottesman K, Sauve M, Rodríguez-Reyna TS, Larche M, van Breda W, Suarez-Almazor ME, Wurz A, Culos-Reed N, Malcarne VL, Mayes MD, Boutron I, Mouthon L, Benedetti A, Thombs BD, SPIN Investigators. The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial. Trials 22(1):856, 2021. e-Pub 2021. PMID: 34838105.
10. Karpes Matusevich AR, Duan Z, Zhao H, Lal LS, Chan W, Suarez-Almazor ME, Giordano SH, Swint JM, Lopez-Olivo MA. Treatment sequences after discontinuing a tumor necrosis factor inhibitor in patients with rheumatoid arthritis. A comparison of cycling versus swapping strategies. Arthritis Care Res (Hoboken) 73(10):1461-1469, 2021. e-Pub 2021. PMID: 32558339.
11. Lopez-Olivo MA, Lin H, Rizvi T, Barbo Barthel A, Ingleshwar A, des Bordes JKA, Jibaja-Weiss M, Volk RJ, Suarez-Almazor ME. Randomized Controlled Trial of Patient Education Tools for Patients with Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 73(10):1470-1478, 2021. e-Pub 2021. PMID: 32583971.
12. Bruera S, Carmona L, Lopez-Olivo MA, Westrich-Robertson T, March L, Negron JB, Christensen R, Strand V, Ingegnoli F, Goel N, Shea B, Tugwell P, Leong A, Bingham CO, Hill CL, Suarez-Almazor ME. Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative. Semin Arthritis Rheum 51(5):1113-1116, 2021. e-Pub 2021. PMID: 34446270.
13. Alfano CM, Suarez-Almazor M, Rodriguez MA, Palos GR, Gilmore KR. Innovating the Personalization of Stratified Survivorship Care Pathways: Using a Cancer Data Ecosystem to Improve Care Access, Outcomes, Efficiency, and Costs. J Natl Cancer Inst Monogr 2021(57):3-9, 2021. PMID: 34478510.
14. Palos GR, Suarez-Almazor ME. Launching an Electronic Patient-Reported Outcomes Initiative in Real-Time Clinical Practice. J Natl Cancer Inst Monogr 2021(57):23-30, 2021. PMID: 34478509.
15. Abdel-Wahab N, Diab A, Yu RK, Futreal A, Criswell LA, Tayar JH, Dadu R, Shannon V, Shete SS, Suarez-Almazor ME. Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors. Cancer Immunol Immunother 70(7):1939-1949, 2021. e-Pub 2021. PMID: 33409738.
16. Berthelsen DB, Woodworth TG, Goel N, Ioannidis JPA, Tugwell P, Devoe D, Williamson P, Terwee CB, Suarez-Almazor ME, Strand V, Leong AL, Conaghan PG, Boers M, Shea BJ, Brooks PM, Simon LS, Furst DE, Christensen R, OMERACT Safety Working Group. Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group. Semin Arthritis Rheum 51(3):607-617, 2021. e-Pub 2021. PMID: 33483129.
17. Toupin-April K, Décary S, de Wit M, Meara A, Barton JL, Fraenkel L, Li LC, Brooks P, Shea B, Stacey D, Légaré F, Lydiatt A, Hofstetter C, Proulx L, Christensen R, Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Jull JE, Campbell W, Alten R, Morgan EM, Kelly A, Kaufman J, Hill S, Maxwell LJ, Guillemin F, Beaton D, El-Miedany Y, Mittoo S, Westrich Robertson T, Bartlett SJ, Singh JA, Mannion M, Nasef SI, de Souza S, Boel A, Adebajo A, Arnaud L, Gill TK, Moholt E, Burt J, Jayatilleke A, Hmamouchi I, Carrott D, Blanco FJ, Mather K, Maharaj A, Sharma S, Caso F, Fong C, Fernandez AP, Mackie S, Nikiphorou E, Jones A, Greer-Smith R, Sloan VS, Akpabio A, Strand V, Umaefulam V, Monti S, Melburn C, Abaza N, Schultz K, Stones S, Kiwalkar S, Srinivasalu H, Constien D, King LK, Tugwell P. Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach. Semin Arthritis Rheum 51(3):593-600, 2021. e-Pub 2021. PMID: 33892937.
18. Lopez-Olivo MA, Zogala RJ, des Bordes J, Zamora NV, Christensen R, Rai D, Goel N, Carmona L, Pratt G, Strand V, Suarez-Almazor ME. Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients with Rheumatoid Arthritis Worldwide: An OMERACT Systematic Review. Arthritis Care Res (Hoboken) 73(5):649-657, 2021. e-Pub 2020. PMID: 32004421.
19. Aldrich J, Pundole X, Tummala S, Palaskas N, Andersen CR, Shoukier M, Abdel-Wahab N, Deswal A, Suarez-Almazor ME. Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors. Arthritis Rheumatol 73(5):866-874, 2021. e-Pub 2021. PMID: 33258544.
20. Kim ST, Pundole X, Dadu R, Lambotte O, Ramos-Casals M, Suarez-Almazor ME. Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis. Immunotherapy 13(6):465-475, 2021. e-Pub 2021. PMID: 33641345.
21. Lopez-Olivo MA, des Bordes JK, Lin H, Volk RJ, Rizvi T, Suarez-Almazor ME. A Randomized Controlled Trial Comparing Two Self-Administered Educational Strategies for Patients With Knee Osteoarthritis. ACR Open Rheumatol 3(3):185-195, 2021. e-Pub 2021. PMID: 33590950.
22. Lopez-Olivo MA, des Bordes JKA, Syed MN, Alemam A, Dodeja A, Abdel-Wahab N, Suarez-Almazor ME. Quality appraisal of educational websites about osteoporosis and bone health. Arch Osteoporos 16(1):28, 2021. e-Pub 2021. PMID: 33566216.
23. Saberian C, Abdel-Wahab N, Abudayyeh A, Rafei H, Joseph J, Rondon G, Whited L, Gruschkus S, Fa'ak F, Daher M, Knape C, Safa H, Shoukier M, Suarez-Almazor ME, Marcotulli M, Ludford K, Gulbis AM, Konopleva M, Ohanian M, Ravandi F, Garcia-Manero G, Oran B, Popat UR, Mehta R, Alousi AM, Daver N, Champlin R, Diab A, Al-Atrash G. Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation. J Immunother Cancer 9(2), 2021. PMID: 33637601.
24. Matusevich ARK, Lai LS, Chan W, Swint JM, Cantor SB, Suarez-Almazor ME, Lopez-Olivo MA. Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis. J Manag Care Spec Pharm 27(1):73-83, 2021. PMID: 33377443.
25. Lu H, Lei X, Zhao H, Elting L, Siricilla M, Ursani MA, Giordano SH, Suarez-Almazor M. Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy is Associated with Decreased Fractures in Women with Breast Cancer. J Bone Miner Res. e-Pub 2021. PMID: 33484602.
26. Suarez-Almazor ME, Pundole X, Abdel-Wahab N, Johnson DB, Gupta D, Glezerman I, Cooksley T, Anderson R, Blidner A, Choi J, Dougan M, Ginex P, Girotra M, Shannon VR, Rapoport BL. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors. Support Care Cancer 28(12):6159-6173, 2020. e-Pub 2020. PMID: 32856212.
27. Shannon VR, Anderson R, Blidner A, Choi J, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson DB, Suarez-Almazor ME, Rapoport BL. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity. Support Care Cancer. e-Pub 2020. PMID: 32880733.
28. Lopez-Olivo MA, Ingleshwar A, Landon GC, Siff SJ, Barbo A, Lin HY, Suarez-Almazor ME. Psychosocial Determinants of Total Knee Arthroplasty Outcomes Two Years After Surgery. ACR Open Rheumatol. e-Pub 2020. PMID: 32969193.
29. Lopez-Olivo MA, Colmegna I, Karpes AR, Qi SR, Zamora NV, Sharma R, Pratt G, Suarez-Almazor ME. Systematic Review of Recommendations on the Use of Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis and Cancer: Reply to a Comment. Arthritis Care Res (Hoboken). e-Pub 2020. PMID: 32961036.
30. Pundole X, Suarez-Almazor ME. Cancer and rheumatoid arthritis. Rheum Dis Clin North Am 46(3):445-462, 2020. e-Pub 2020. PMID: 32631599.
31. Pundole X, Zamora NV, Siddhanamatha H, Lin H, Tayar J, Leung CH, Li L, Suarez-Almazor ME. Overall survival in patients with rheumatoid arthritis and solid malignancies receiving biologic disease-modifying antirheumatic therapy. Clin Rheumatol. e-Pub 2020. PMID: 32803571.
32. Blidner AG, Choi J, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Anderson R. Cancer immunotherapy-related adverse events: causes and challenges. Support Care Cancer. e-Pub 2020. PMID: 32857220.
33. Cooksley T, Girotra M, Ginex P, Gordon RA, Anderson R, Blidner A, Choi J, Dougan M, Glezerman I, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities. Support Care Cancer. e-Pub 2020. PMID: 32856213.
34. Choi J, Anderson R, Blidner A, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Lacouture ME. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors. Support Care Cancer. e-Pub 2020. PMID: 32856211.
35. Dougan M, Blidner AG, Choi J, Cooksley T, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Anderson R, Rapoport BL. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors. Support Care Cancer. e-Pub 2020. PMID: 32856210.
36. Suarez-Almazor ME, Herrera R, Lei X, Chavez-MacGregor M, Zhao H, Giordano SH. Survival in older women with early stage breast cancer receiving low-dose bisphosphonates or denosumab. Cancer. e-Pub 2020. PMID: 32573777.
37. Ramos-Casals M, Brahmer JR, Callahan MK, Flores-Chávez A, Keegan N, Khamashta MA, Lambotte O, Mariette X, Prat A, Suárez-Almazor ME. Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers 6(1):38, 2020. e-Pub 2020. PMID: 32382051.
38. Fortuné C, Gietzen A, Guillot G, Lewis N, Nielsen K, Richard M, Sauvé M, Welling J, SPIN Investigators, Baron M, Furst DE, Gottesman K, Malcarne V, Mayes MD, Mouthon L, Nielson WR, Riggs R, Wigley F, Assassi S, Boutron I, Ells C, van den Ende C, Fligelstone K, Frech T, Godard D, Harel D, Hinchcliff M, Hudson M, Johnson SR, Larche M, Leite C, Nguyen C, Pope J, Portales A, Rannou F, Reyna TSR, Schouffoer AA, Suarez-Almazor ME, Agard C, Albert A, André M, Arsenault G, Benzidia I, Bernstein EJ, Berthier S, Bissonnette L, Boire G, Bruns A, Carreira P, Casadevall M, Chaigne B, Chung L, Cohen P, Correia C, Dagenais P, Denton C, Domsic R, Dubois S, Dunne JV, Dunogue B, Fare R, Farge-Bancel D, Fortin PR, Gill A, Gordon J, Granel-Rey B, Gyger G, Hachulla E, Hatron PY, Herrick AL, Hij A, Hoa S, Ikic A, Jones N, Fernandes AJB, Kafaja S, Khalidi N, Lambert M, Launay D, Liang P, Maillard H, Maltez N, Manning J, Marie I, Martin M, Martin T, Masetto A, Maurier F, Mekinian A, Melchor S, Nikpour M, Olagne L, Poindron V, Proudman S, Régent A, Rivière S, Robinson D, Rodriguez E, Roux S, Smets P, Smith D, Sobanski V, Spiera R, Steen V, Stevens W, Sutton E, Terrier B, Thorne C, Varga J, Wilcox P, Ayala MC, Ostbo N, Thombs BD, Kwakkenbos L, Carrier ME, Bourgeault A, Tao L, Harb S, Gagarine M, Rice D, Bustamante L, Ellis K, Duchek D, Wu Y, Bhandari PM, Neupane D, Carboni-Jiménez A, Henry RS, Krishnan A, Sun Y, Levis B, He C, Turner KA, Benedetti A, Culos-Reed N, El-Baalbaki G, Hebblethwaite S, Bartlett SJ, Dyas L, Patten S, Varga J, Scleroderma Patient-centered Intervention Network (SPIN), COVID-19 Patient Advisory Team. Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. J Psychosom Res:110132. e-Pub 2020. PMID: 32419703.
39. Carrier ME, Kwakkenbos L, Nielson WR, Fedoruk C, Nielsen K, Milette K, Pope J, Frech T, Gholizadeh S, Hummers L, Johnson SR, Piotrowski P, Jewett L, Gordon J, Chung L, Bilsker D, Turner KA, Cumin J, Welling J, Fortune C, Leite C, Gottesman K, Sauve M, Rodríguez-Reyna TS, Hudson M, Larche M, van Breda W, Suarez-Almazor ME, Bartlett SJ, Malcarne VL, Mayes MD, Boutron I, Mouthon L, Wigley F, Thombs BD, SPIN Investigators. The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility Trial. JMIR Res Protoc 9(4):e16799, 2020. e-Pub 2020. PMID: 32329747.
40. Torres HA, Lok AS, Suarez-Almazor ME, Warneke CL, Kaseb A, Miller E, Sturgis EM, Foreman JT, Angelidakis G, Ahmed S, Ferrajoli A, Samaniego F, Hawk ET, Hwang JP. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. e-Pub 2020. PMID: 32314052.
41. Abdel-Wahab N, Tayar JH, Fa'ak F, Sharma G, Lopez-Olivo MA, Yousif A, Shagroni T, Al-Hawamdeh S, Rojas-Hernandez CM, Suarez-Almazor ME. Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. Blood Adv 4(8):1746-1755, 2020. PMID: 32337583.
42. Karpes Matusevich AR, Suarez-Almazor ME, Cantor SB, Lal LS, Swint JM, Lopez-Olivo MA. Systematic review of economic evaluations of cycling versus swapping in patients with rheumatoid arthritis after failure to tumor necrosis factor inhibitors. Arthritis Care Res (Hoboken) 72(3):343-352, 2020. e-Pub 2019. PMID: 30801951.
43. Pundole X, Zamora NV, Siddhanamatha H, Lin H, Tayar J, Hong LC, Li L, Suarez-Almazor ME. Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer. Clin Rheumatol 39(3):787-794, 2020. e-Pub 2019. PMID: 31853733.
44. Sonawane K, Zhu Y, Chan W, Aguilar D, Deshmukh AA, Suarez-Almazor ME. Association of Serum Folate Levels With Cardiovascular Mortality Among Adults With Rheumatoid Arthritis. JAMA Netw Open 3(2):e200100, 2020. e-Pub 2020. PMID: 32101310.
45. des Bordes J, Prasad S, Pratt G, Suarez-Almazor ME, Lopez-Olivo MA. Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies. PLoS One 15(1):e0227765, 2020. e-Pub 2020. PMID: 31940409.
46. des Bordes JKA, Foreman J, Westrich-Robertson T, Lopez-Olivo MA, Peterson SK, Hofstetter C, Lyddiatt A, Willcockson I, Leong A, Suarez-Almazor ME. Interactions and perceptions of patients with rheumatoid arthritis participating in an online support group. Clin Rheumatol. e-Pub 2020. PMID: 32006180.
47. Becetti K, Kwakkenbos L, Carrier ME, Gordon JK, Nguyen JT, Mancuso CA, Mouthon L, Nguyen C, Rannou F, Welling J, Thombs BD, Spiera RF, SPIN Investigators. Physical or Occupational Therapy Use in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study. J Rheumatol 46(12):1605-1613, 2019. e-Pub 2019. PMID: 31043542.
48. Lopez-Olivo MA, des Bordes JKA, Lin H, Rizvi T, Volk RJ, Suarez-Almazor ME. Comparison of multimedia and printed patient education tools for patients with osteoporosis: a 6-month randomized controlled trial. Osteoporos Int. e-Pub 2019. PMID: 31844906.
49. Abdel-Wahab N, Suarez-Almazor ME. Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy. Rheumatology (Oxford) 58(Supplement_7):vii40-vii48, 2019. PMID: 31816084.
50. Safa H, Johnson DH, Trinh VA, Rodgers TE, Lin H, Suarez-Almazor ME, Fa'ak F, Saberian C, Yee C, Davies MA, Tummala S, Woodman K, Abdel-Wahab N, Diab A. Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature. J Immunother Cancer 7(1):319, 2019. e-Pub 2019. PMID: 31753014.
51. Michaud K, Vrijens B, Tousset E, Pedro S, Schumacher R, Dasic G, Chen C, Agarwal E, Suarez-Almazor ME. Real-World Adherence to Oral Methotrexate Measured Electronically in Patients With Established Rheumatoid Arthritis. ACR Open Rheumatol 1(9):560-570, 2019. e-Pub 2019. PMID: 31777840.
52. Toupin-April K, Barton JL, Fraenkel L, Meara A, Li LC, Brooks P, de Wit M, Stacey D, Légaré F, Shea B, Lyddiatt A, Hofstetter C, Christensen R, Scholte Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Jull JE, Campbell W, Alten R, Karuranga S, Morgan EM, Kelly A, Kaufman J, Hill S, Maxwell LJ, Beaton D, El-Miedany Y, Mittoo S, Bartlett SJ, Singh JA, Tugwell PS. Development of a core domain set of outcomes for shared decision making interventions: An Omeract white paper and stakeholder interviews. J Rheumatol 46(10):1409-1414, 2019. e-Pub 2019. PMID: 30709963.
53. Lo GH, Ikpeama UE, Driban JB, Kriska AM, McAlindon TE, Petersen NJ, Storti KL, Eaton CB, Hochberg MC, Jackson RD, Kwoh CK, Nevitt MC, Suarez-Almazor ME. Evidence that Swimming May Be Protective of Knee Osteoarthritis: Data from the Osteoarthritis Initiative. PM R. e-Pub 2019. PMID: 31628825.
54. Kwakkenbos L, Cumin J, Carrier ME, Bartlett SJ, Malcarne VL, Mouthon L, Nielson WR, Rannou F, Welling J, Thombs BD, SPIN Investigators. Factors associated with patient-reported likelihood of using online self-care interventions: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study. BMJ Open 9(10):e029542, 2019. e-Pub 2019. PMID: 31615796.
55. Pundole XN, Sarangdhar M, Suarez-Almazor ME. Rheumatic and musculoskeletal adverse events with immune checkpoint inhibitors: Data from the United States Food and Drug Administration adverse event reporting system. J Immunother Precis Oncol. e-Pub 2019.
56. Uhrenholt L, Schlemmer A, Hauge EM, Christensen R, Dreyer L, Suarez-Almazor ME, Kristensen S. Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial). BMJ Open 9(7):e028517, 2019. e-Pub 2019. PMID: 31292181.
57. Abdel-Wahab N, Safa H, Abudayyeh A, Johnson DH, Trinh VA, Zobniw CM, Lin H, Wong MK, Abdelrahim M, Gaber AO, Suarez-Almazor ME, Diab A. Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. J Immunother Cancer 7(1):158, 2019. e-Pub 2019. PMID: 31234936.
58. Klokker L, Berthelsen DB, Woodworth T, Andersen KM, Furst DE, Devoe D, Williamson PR, Suarez-Almazor ME, Strand V, Leong AL, Goel N, Boers M, Brooks PM, March L, Sloan VS, Tugwell P, Simon LS, Christ R. Identifying possible outcome domains from existing outcome measures to inform an OMERACT core domain set for safety in rheumatology trials. J Rheumatol. e-Pub 2019. PMID: 31043547.
59. Kim ST, Bittar M, Kim HJ, Neelapu SS, Zurita AJ, Nurieva R, Suarez-Almazor ME. Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flare. J Immunother Cancer 7(1):126, 2019. e-Pub 2019. PMID: 31088575.
60. Singh JA, Fraenkel L, Green C, Alarcón GS, Barton JL, Saag KG, Hanrahan LM, Raymond SC, Kimberly RP, Leong AL, Reyes E, Street RL, Suarez-Almazor ME, Eakin GS, Marrow L, Morgan CJ, Caro B, Sloan JA, Jandali B, Garcia SR, Grossman J, Winthrop KL, Trupin L, Dall'Era M, Meara A, Rizvi T, Chatham WW, Yazdany J. Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial. PLoS Med 16(5):e1002800, 2019. e-Pub 2019. PMID: 31067237.
61. Ramos-Casals M, Maria A, Suárez-Almazor ME, Lambotte O, Fisher BA, Hernández-Molina G, Guilpain P, Pundole X, Flores-Chávez A, Baldini C, Bingham Iii CO, Brito-Zerón P, Gottenberg JE, Kostine M, Radstake TRD, Schaeverbeke T, Schulze-Koops H, Calabrese L, Khamashta MA, Mariette X, ICIR. Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR). Clin Exp Rheumatol 37 Suppl 118(3):114-122, 2019. e-Pub 2019. PMID: 31464670.
62. Abdel-Wahab N, Safa H, Abudayyeh A, Johnson DH, Trinh VA, Zobniw CM, Lin H, Wong MK, Abdelrahim M, Gaber AO, Suarez-Almazor ME, Diab A. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. J Immunother Cancer 7(1):106, 2019. e-Pub 2019. PMID: 30992053.
63. Lopez-Olivo MA, Negrón JB, Zogala RJ, Carmona L, Criner K, Goel N, Gonzalez-Lopez L, Ingegnoli F, Leong A, March L, Shea B, Strand V, Tugwell P, Westrich-Robertson T, Zamora NV, Christensen R, Suarez-Almazor ME. Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis. J Rheumatol. e-Pub 2019. PMID: 30824644.
64. Hwang JP, Huang D, Vierling JM, Suarez-Almazor ME, Shih YT, Chavez-MacGregor M, Duan Z, Giordano SH, Hershman DL, Fisch MJ, Cantor SB. Cost-effectiveness analysis of hepatitis B virus screening and management in patients with hematologic or solid malignancies anticipating immunosuppressive cancer therapy. JCO Clin Cancer Inform 3:1-12, 2019. PMID: 30892921.
65. Shah M, Tayar JH, Abdel-Wahab N, Suarez-Almazor ME. Myositis as an adverse event of immune checkpoint blockade for cancer therapy. Semin Arthritis Rheum 48(4):736-740, 2019. e-Pub 2018. PMID: 29909921.
66. Harel D, Mills SD, Kwakkenbos L, Carrier ME, Nielsen K, Portales A, Bartlett SJ, Malcarne VL, Thombs BD, and the SPIN Investigators. Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort. BMJ Open 9(2):e024010, 2019. e-Pub 2019. PMID: 30798308.
67. Lopez-Olivo MA, Colmegna I, Karpes AR, Qi SR, Zamora NV, Sharma R, Pratt G, Suarez-Almazor ME. Systematic review of recommendations on the use of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and cancer. Arthritis Care Res (Hoboken). e-Pub 2019. PMID: 30821928.
68. Mamlouk O, Selamet U, Machado S, Abdelrahim M, Glass WF, Tchakarov A, Gaber L, Lahoti A, Workeneh B, Chen S, Lin J, Abdel-Wahab N, Tayar J, Lu H, Suarez-Almazor M, Tannir N, Yee C, Diab A, Abudayyeh A. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. J Immunother Cancer 7(1):2, 2019. e-Pub 2019. PMID: 30612580.
69. Abdel-Wahab N, Rai D, Siddhanamatha H, Dodeja A, Suarez-Almazor ME, Lopez-Olivo MA. A comprehensive scoping review to identify standards for the development of health information resources on the internet. PLoS One 14(6):e0218342, 2019. e-Pub 2019. PMID: 31220126.
70. Fox RS, Kwakkenbos L, Carrier ME, Mills SD, Gholizadeh S, Jewett LR, Roesch SC, Merz EL, Assassi S, Furst DE, Gottesman K, Mayes MD, Thombs BD, Malcarne VL, SPIN Investigators. Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Arthritis Care Res (Hoboken) 70(11):1646-1652, 2018. PMID: 29409146.
71. Huynh C, Puyraimond-Zemmour D, Maillefert JF, Conaghan PG, Davis AM, Gunther KP, Hawker G, Hochberg MC, Kloppenburg M, Lim K, Lohmander LS, Mahomed NN, March L, Pavelka K, Punzi L, Roos EM, Sanchez-Riera L, Singh JA, Suarez-Almazor ME, Dougados M, Gossec L. Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients. Osteoarthritis Cartilage 26(10):1311-1318, 2018. e-Pub 2018. PMID: 30017727.
72. Tarp S, Jørgensen TS, Furst DE, Dossing A, Taylor PC, Choy EH,Suarez-Almazor ME, Lyddiatt A, Kristensen LE, Bliddal H, Christensen R. Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trials. Semin Arthritis Rheum. e-Pub 2018. PMID: 30396592.
73. Lu H, Lok AS, Warneke CL, Ahmed S, Torres HA, Martinez F,Suarez-Almazor ME, Foreman JT, Ferrajo A, Hwang JP. Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review. Lancet Haematol 5(10):e474-e478, 2018. PMID: 30290904.
74. Mills SD, Kwakkenbos L, Carrier ME, Gholizadeh S, Fox RS, Jewett LR, Gottesman K, Roesch SC, Thombs BD, Malcarne VL, Scleroderma Patient-centered Intervention Network Investigators. Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Arthritis Care Res (Hoboken) 70(10):1557-1562, 2018. PMID: 29342510.
75. Lo GH, Musa SM, Driban JB, Kriska AM, McAlindon TE, Souza RB, Petersen NJ, Storti KL, Eaton CB, Hochberg MC, Jackson RD, Kwoh CK, Nevitt MC, Suarez-Almazor ME. Running does not increase symptoms or structural progression in people with knee osteoarthritis: data from the osteoarthritis initiative. Clin Rheumatol 37(9):2497-2504, 2018. e-Pub 2018. PMID: 29728929.
76. des Bordes JKA, Gonzalez E, Lopez-Olivo MA, Shethia M, Nayak P, Suarez-Almazor ME. Assessing information needs and use of online resources for disease self-management in patients with rheumatoid arthritis: a qualitative study. Clin Rheumatol 37(7):1791-1797, 2018. e-Pub 2018. PMID: 29500557.
77. Abdel-Wahab N, Shah M, Lopez-Olivo MA, Suarez-Almazor ME. Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease. Ann Intern Med 169(2):133-134, 2018. PMID: 30014109.
78. Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, Ramondetta L, Parker SL, Suarez-Almazor ME, Ferrajoli A, Shih YT, Giordano SH, Chiao EY. Low rate of cervical cancer screening among women with hematologic malignancies after stem cell transplant. Biol Blood Marrow Transplant 24(5):1094-1098, 2018. e-Pub 2018. PMID: 29378304.
79. Manzano JM, Yang M, Zhao H, Elting LS, George MC, Luo R, Suarez-Almazor ME. Readmission patterns after GI cancer hospitalizations: The medical versus surgical patient. J Oncol Pract 14(3):e137-e148, 2018. e-Pub 2018. PMID: 29443648.
80. Kelly A, Tong A, Tymms K, March L, Craig JC, De Vera M, Evans V, Hassett G, Toupin-April K, van den Bemt B, Teixeira-Pinto A, Alten R, Bartlett SJ, Campbell W, Dawson T, Gill M, Hebing R, Meara A, Nieuwlaat R, Shaw Y, Singh JA, Suarez-Almazor M, Sumpton D, Wong P, Christensen R, Beaton D, de Wit M, Tugwell P, OMERACT-Adherence Group. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol. Trials 19(1):204, 2018. e-Pub 2018. PMID: 29587864.
81. Merz EL, Kwakkenbos L, Carrier ME, Gholizadeh S, Mills SD, Fox RS, Jewett LR, Williamson H, Harcourt D, Assassi S, Furst DE, Gottesman K, Mayes MD, Moss TP, Thombs BD, Malcarne VL, SPIN Investigators. Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study. BMJ Open 8(3):e018641, 2018. e-Pub 2018. PMID: 29511009.
82. Lopez-Olivo MA, Ingleshwar A, Volk RJ, Jibaja-Weiss M, Barbo A, Saag K, Leong A, Suarez-Almazor ME. Development and pilot testing of multimedia patient education tools for patients with knee osteoarthritis, osteoporosis, and rheumatoid arthritis. Arthritis Care Res (Hoboken) 70(2):213-220, 2018. e-Pub 2017. PMID: 28464546.
83. Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo A, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr BP, Miller E, Eng C, Simon GR, Ahmed S, Ferrajoli A, Romaguera J, Suarez-Almazor ME. Models to predict Hepatitis B virus infection among patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study. J Clin Oncol:JCO2017756387. e-Pub 2018. PMID: 29447061.
84. Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline. J Clin Oncol:JCO2017776385. e-Pub 2018. PMID: 29442540.
85. Abdel-Wahab N, Shah M, Lopez-Olivo MA, Suarez-Almazor ME. Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: A systematic review. Ann Intern Med 168(2):121-130, 2018. e-Pub 2018. PMID: 29297009.
86. Klokker L, Tugwell P, Furst DE, Devoe D, Williamson P, Terwee CB, Suarez-Almazor ME, Strand V, Woodworth T, Leong AL, Goel N, Boers M, Brooks PM, Simon LS, Christensen R. Developing an OMERACT core outcome set for assessing safety components in rheumatology trials: The OMERACT safety working group. J Rheumatol 44(12):1916-1919, 2017. e-Pub 2016. PMID: 27744393.
87. Kim ST, Tayar J, Trinh VA, Suarez-Almazor M, Garcia S, Hwu P, Johnson DH, Uemura M, Diab A. Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series. Ann Rheum Dis 76(12):2061-2064, 2017. e-Pub 2017. PMID: 28830882.
88. Zamora NV, Christensen R, Goel N, Klokker L, Lopez-Olivo MA, Kristensen LE, Carmona L, Strand V, Curtis JR, Suarez-Almazor ME. Critical outcomes in longitudinal observational studies and registries in patients with rheumatoid arthritis: An OMERACT special interest group report. J Rheumatol 44(12):1894-1898, 2017. e-Pub 2017. PMID: 28620065.
89. Lopez-Olivo MA, Kakpovbia-Eshareturi V, des Bordes J, Barbo A, Christensen R, Suarez-Almazor ME. Treating early undifferentiated arthritis: A systematic review and meta-analysis of direct and indirect trial evidence. Arthritis Care Res (Hoboken). e-Pub 2017. PMID: 29161466.
90. Fujii T, Colen RR, Bilen MA, Hess KR, Hajjar J, Suarez-Almazor ME, Alshawa A, Hong DS, Tsimberidou A, Janku F, Gong J, Stephen B, Subbiah V, Piha-Paul SA, Fu S, Sharma P, Mendoza T, Patel A, Thirumurthi S, Sheshadri A, Meric-Bernstam F, Naing A. Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. e-Pub 2017. PMID: 29159766.
91. Puzanov I, Diab A, Abdallah K, Bingham CO, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D,Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS, Society for Immunotherapy of Cancer Toxicity Management Working Group. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. J Immunother Cancer 5(1):95, 2017. e-Pub 2017. PMID: 29162153.
92. des Bordes JKA, Suarez-Almazor ME, Volk RJ, Lu H, Edwards B, Lopez-Olivo MA. Online educational tool to promote bone health in cancer survivors. J Health Commun 22(10):1-10, 2017. e-Pub 2017. PMID: 28922062.
93. Toupin-April K, Barton J, Fraenkel L, Li LC, Brooks P, De Wit M, Stacey D, Légaré F, Meara A, Shea B, Lyddiatt A, Hofstetter C, Gossec L, Christensen R, Scholte-Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Pohl C, Jull JE, Sivarajah S, Campbell W, Alten R, Karuranga S, Morgan E, Kaufman J, Hill S, Maxwell LJ, Welch V, Beaton D, El-Miedany Y, Tugwell PS. Toward the development of a core set of outcome domains to assess shared decision-making interventions in rheumatology: Results from an OMERACT delphi survey and consensus meeting. J Rheumatol 44(10):1544-1550, 2017. e-Pub 2017. PMID: 28765239.
94. Colen RR, Fujii T, Bilen MA, Kotrotsou A, Abrol S, Hess KR, Hajjar J, Suarez-Almazor ME, Alshawa A, Hong DS, Giniebra-Camejo D, Stephen B, Subbiah V, Sheshadri A, Mendoza T, Fu S, Sharma P, Meric-Bernstam F, Naing A. Radiomics to predict immunotherapy-induced pneumonitis: Proof of concept. Invest New Drugs. e-Pub 2017. PMID: 29075985.
95. Landsittel DP, Kessler L, Schmid CH, Marantz P, Suarez-Almazor ME. Training in patient-centered outcomes research for specific researcher communities. J Clin Transl Sci 1(5):278-284, 2017. PMID: 29707248.
96. Hwang JP, Suarez-Almazor ME, Cantor SB, Barbo A, Lin HY, Ahmed S, Chavez-MacGregor M, Donato-Santana C, Eng C, Ferrajoli A, Fisch MJ, McLaughlin P, Simon GR, Rondon G, Shpall EJ, Lok AS. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy. Cancer 123(17):3367-76, 2017. e-Pub 2017. PMID: 28518219.
97. Lo GH, McAlindon TE, Katz JN, Driban JB, Price LL, Eaton CB, Petersen NJ, Ballantyne CM, Suarez-Almazor ME. Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis Initiative. Clin Rheumatol 36(9):2121-2128, 2017. e-Pub 2017. PMID: 28573369.
98. Tarp S, Furst DE, Dossing A, Østergaard M, Lorenzen T, Hansen MS, Singh JA, Choy EH, Boers M, Suarez-Almazor ME, Kristensen LE, Bliddal H, Christensen R. Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials. Semin Arthritis Rheum 46(6):699-708, 2017. e-Pub 2016. PMID: 27769592.
99. Siddhanamatha HR, Heung E, Lopez-Olivo MLA, Abdel-Wahab N, Ojeda-Prias A, Willcockson I, Leong A, Suarez-Almazor ME. Quality assessment of websites providing educational content for patients with rheumatoid arthritis. Semin Arthritis Rheum 46(6):715-723, 2017. e-Pub 2017. PMID: 28258768.
100. Escalante CP, Gladish GW, Qiao W, Zalpour A, Assylbekova B, Gao S, Olejeme KA, Richardson MN, Suarez-Almazor ME. Prospective cohort study of cancer patients diagnosed with incidental venous thromboembolism on routine computed tomography scans. Support Care Cancer 25(5):1571-1577, 2017. e-Pub 2017. PMID: 28070669.
101. Pundole X, Cheema HI, Petitto GS, Lopez-Olivo MA, Suarez-Almazor ME, Lu H. Prevention and treatment of bone loss and fractures in patients undergoing a hematopoietic stem cell transplant: a systematic review and meta-analysis. Bone Marrow Transplant 52(5):663-670, 2017. e-Pub 2017. PMID: 28112742.
102. Singh JA, Hossain A, Mudano AS, Tanjong Ghogomu E, Suarez-Almazor ME, Buchbinder R, Maxwell LJ, Tugwell P, Wells GA. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database Syst Rev 5:CD012657, 2017. e-Pub 2017. PMID: 28481462.
103. Zogala RJ, Goutsouliak K, Suarez-Almazor ME. Management considerations in cancer patients With rheumatoid arthritis. Oncology (Williston Park) 31(5):374-80, 2017. PMID: 28516435.
104. Suarez-Almazor ME, Kim ST, Abdel-Wahab N, Diab A. Review: Immune-related adverse events with use of checkpoint inhibitors for immunotherapy of cancer. Arthritis Rheumatol 69(4):687-699, 2017. e-Pub 2017. PMID: 28085999.
105. Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Maxwell LJ, Buchbinder R, Lopez-Olivo MA, Suarez-Almazor ME, Tugwell P, Wells GA. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev 3:CD012591, 2017. e-Pub 2017. PMID: 28282491.
106. Pan X, Lopez-Olivo MA, Song J, Pratt G, Suarez-Almazor ME. Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis. BMJ Open 7(3):e013242, 2017. e-Pub 2017. PMID: 28249848.
107. Lo GH, Driban JB, Kriska AM, McAlindon TE, Souza RB, Petersen NJ, Storti KL, Eaton CB, Hochberg MC, Jackson RD, Kent Kwoh C, Nevitt MC, Suarez-Almazor ME. History of running is not associated with higher risk of symptomatic knee osteoarthritis: A cross-sectional study from the osteoarthritis initiative. Arthritis Care Res (Hoboken) 69(2):183-191, 2017. e-Pub 2016. PMID: 27333572.
108. Nayak P, Luo R, Elting L, Zhao H, Suarez-Almazor ME. Impact of rheumatoid arthritis on the mortality of elderly patients who develop cancer: A population-based study. Arthritis Care Res (Hoboken) 69(1):75-83, 2017. e-Pub 2016. PMID: 27483088.
109. Senftleber NK, Nielsen SM, Andersen JR, Bliddal H, Tarp S, Lauritzen L, Furst DE, Suarez-Almazor ME, Lyddiatt A, Christensen R. Marine oil supplements for arthritis pain: A systematic review and meta-analysis of randomized trials. Nutrients 9(1), 2017. e-Pub 2017. PMID: 28067815.
110. Abdel-Wahab N, Talathi S, Lopez-Olivo MA, Suarez-Almazor ME. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. Lupus:961203317731532. e-Pub 2017. PMID: 28945149.
111. Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus 25(14):1520-1531, 2016. e-Pub 2016. PMID: 27060064.
112. Levis AW, Harel D, Kwakkenbos L, Carrier ME, Mouthon L, Poiraudeau S, Bartlett SJ, Khanna D, Malcarne VL, Sauve M, van den Ende CH, Poole JL, Schouffoer AA, Welling J, Thombs BD, and the Scleroderma Patient-Centered Intervention Network Investigators. Using optimal test assembly methods for shortening patient-reported outcome measures: Development and validation of the cochin hand function scale-6: A scleroderma patient-centered Intervention Network Cohort Study. Arthritis Care Res (Hoboken) 68(11):1704-1713, 2016. e-Pub 2016. PMID: 27015290.
113. Riehm KE, Kwakkenbos L, Carrier ME, Bartlett SJ, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Nielsen K, Baron M, Frech T, Hudson M, Pope J, Sauve M, Suarez-Almazor ME, Wigley FM, Thombs BD, Scleroderma Patient-Centered Intervention Network Investigators. Validation of the Self-Efficacy for Managing Chronic Disease (SEMCD) Scale: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study. Arthritis Care Res (Hoboken) 68(8):1195-200, 2016. e-Pub 2015. PMID: 26619042.
114. Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, Lopez-Olivo MA, Barbo AG, Landon GC, Siff SJ, Lin H, Suarez-Almazor ME. Effect of body mass index and psychosocial traits on total knee replacement costs in patients with osteoarthritis. J Rheumatol 43(8):1600-6, 2016. e-Pub 2016. PMID: 27307528.
115. Hsiao-Wei Lo G, Balasubramanyam AS, Barbo A, Street RL, Suarez-Almazor ME. Mediated by self-efficacy status, positive clinician conveyed expectations of treatment effect reduces pain in knee osteoarthritis. Arthritis Care Res (Hoboken) 68(7):952-7, 2016. e-Pub 2015. PMID: 26554869.
116. des Bordes JK, Abdel-Wahab N, Suarez-Almazor ME, Lopez-Olivo MA. Assessing information needs on bone health in cancer survivors. J Cancer Surviv 10(3):480-8, 2016. e-Pub 2015. PMID: 26499252.
117. de Achaval S, Kallen MA, Amick B, Landon G, Siff S, Edelstein D, Zhang H, Suarez-Almazor ME. Patients' expectations about total knee arthroplasty outcomes. Health Expect 19(2):299-308, 2016. e-Pub 2015. PMID: 25684135.
118. Abdel-Wahab N, Shah M, Suarez-Almazor ME. Adverse events associated with immune checkpoint blockade in patients with cancer: A systematic review of case reports. PLoS One 11(7):e0160221, 2016. e-Pub 2016. PMID: 27472273.
119. Marengo MF, Suarez-Almazor ME. Improving treatment adherence in patients with rheumatoid arthritis: what are the options?. Int J Clin Rheumtol 10(5):345-356, 2015. PMID: 27087857.
120. Busse JW, Bartlett SJ, Dougados M, Johnston BC, Guyatt GH, Kirwan JR, Kwoh K, Maxwell LJ, Moore A, Singh JA, Stevens R, Strand V, Suarez-Almazor ME, Tugwell P, Wells GA. Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop. J Rheumatol 42(10):1962-1970, 2015. e-Pub 2015. PMID: 25979719.
121. Gao J, He Q, Subudhi S, Aparicio A, Zurita-Saavedra A, Lee DH, Jimenez C, Suarez-Almazor M, Sharma P. Review of immune-related adverse events in prostate cancer patients treated with ipilimumab: MD Anderson experience. Oncogene 34(43):5411-7, 2015. e-Pub 2015. PMID: 25659583.
122. Hwang JP, Granwehr BP, Torres HA, Suarez-Almazor ME, Giordano TP, Barbo AG, Lin HY, Fisch MJ, Chiao EY. HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract 11(5):384-90, 2015. e-Pub 2015. PMID: 26243649.
123. Buscher AL, Kallen MA, Suarez-Almazor ME, Giordano TP. Development of an "Impact of HIV" instrument for HIV survivors. J Assoc Nurses AIDS Care. e-Pub 2015. PMID: 26324524.
124. Toupin-April K, Barton J, Fraenkel L, Li L, Grandpierre V, Guillemin F, Rader T, Stacey D, Légaré F, Jull J, Petkovic J, Scholte-Voshaar M, Welch V, Lyddiatt A, Hofstetter C, De Wit M, March L, Meade T, Christensen R, Gaujoux-Viala C, Suarez-Almazor ME, Boonen A, Pohl C, Martin R, Tugwell PS. Development of a draft core set of domains for measuring shared decision making in osteoarthritis: An OMERACT working group on shared decision making. J Rheumatol. e-Pub 2015. PMID: 25877502.
125. Lopez-Olivo MA, Amezaga Urruela M, McGahan L, Pollono EN, Suarez-Almazor ME. Rituximab for rheumatoid arthritis. Cochrane Database Syst Rev 1:CD007356, 2015. e-Pub 2015. PMID: 25603545.
126. Street RL, Marengo MF, Barbo A, Lin H, Gonzalez AG, Richardson MN, Suarez-Almazor ME. Affective tone in medical encounters and its relationship with treatment adherence in a multiethnic cohort of patients with rheumatoid arthritis. J Clin Rheumatol 21(4):181-8, 2015. PMID: 26010180.
127. Manzano J, Luo R, Elting L, George M, Suarez-Almazor ME. Patterns and predictors of unplanned hospitalization in a population-based cohort of elderly patients with GI cancer. Journal of Clinical Oncology(32(31):3527-3533). e-Pub 2015. PMID: 25287830.
128. Pan X, Lopez-Olivo MA, Nayak P, Suarez-Almazor ME. Quality assessment of controlled trials evaluating Chinese herbal medicine in patients With rheumatoid arthritis: A systematic review. Value Health 17(7):A547, 2014. e-Pub 2014. PMID: 27201776.
129. Bruera S, Lopez-Olivo MA, Barbo A, Suarez-Almazor ME. Use of medication reminders in patients with rheumatoid arthritis. Value Health 17(7):A384, 2014. e-Pub 2014. PMID: 27200863.
130. Hwang JP, Suarez-Almazor ME, Torres HA, Palla SL, Huang DS, Fisch MJ, Lok AS. Hepatitis C virus screening in patients with cancer receiving chemotherapy. J Oncol Pract 10(3):e167-74, 2014. e-Pub 2014. PMID: 24594679.
131. Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, Lopez-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Cost-effectiveness of total knee replacement: A prospective cohort study. Arthritis Care Res (Hoboken) 66(4):592-9, 2014. e-Pub 2013. PMID: 24124052.
132. Suarez-Almazor ME, Peddi P, Luo R, Nguyen HT, Elting LS. Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy. Support Care Cancer 22(2):537-44, 2014. e-Pub 2013. PMID: 24146343.
133. Singh JA, Luo R, Landon GC, Suarez-Almazor M. Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: A multicenter study. J Rheumatol. e-Pub 2014. PMID: 24429183.
134. Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME. Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev 6:CD000957, 2014. e-Pub 2014. PMID: 24916606.
135. Manzano JG, Luo R, Elting LS, George M, Suarez-Almazor ME. Patterns and predictors of unplanned hospitalization in a population-based cohort of elderly patients with GI cancer. J Clin Oncol 32(31):3527-33, 2014. e-Pub 2014. PMID: 25287830.
136. Peddi P, Lopez-Olivo MA, Pratt GF, Suarez-Almazor ME. Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis. Cancer Treat Rev 39(1):97-104, 2013. e-Pub 2012. PMID: 22898302.
137. de Achaval S, Feudtner C, Palla S, Suarez-Almazor ME. Validation of ICD-9-CM codes for identification of acetaminophen-related emergency department visits in a large pediatric hospital. BMC Health Serv Res 13:72, 2013. e-Pub 2013. PMID: 23433397.
138. Giordano TP, Rodriguez S, Zhang H, Kallen MA, Jibaja-Weiss M, Buscher AL, Arya M, Suarez-Almazor ME, Ross M. Effect of a clinic-wide social marketing campaign to improve adherence to antiretroviral therapy for HIV infection. AIDS Behav 17(1):104-12, 2013. PMID: 22983536.
139. Waimann CA, Marengo MF, de Achaval S, Cox VL, Garcia-Gonzalez A, Reveille JD, Richardson MN, Suarez-Almazor ME. Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence. Arthritis Rheum 65(6):1421-9, 2013. PMID: 23728826.
140. de Achaval S, Kallen MA, Mayes MD, Lopez-Olivo MA, Suarez-Almazor ME. Use of the patient-generated index in systemic sclerosis to assess patient-centered outcomes. J Rheumatol 40(8):1337-43, 2013. e-Pub 2013. PMID: 23772081.
141. Kwakkenbos L, Jewett LR, Baron M, Bartlett SJ, Furst D, Gottesman K, Khanna D, Malcarne VL, Mayes MD, Mouthon L, Poiraudeau S, Sauve M, Nielson WR, Poole JL, Assassi S, Boutron I, Ells C, van den Ende CH, Hudson M, Impens A, Körner A, Leite C, Costa Maia A, Mendelson C, Pope J, Steele RJ, Suarez-Almazor ME, Ahmed S, Coronado-Montoya S, Delisle VC, Gholizadeh S, Jang Y, Levis B, Milette K, Mills SD, Razykov I, Fox RS, Thombs BD. The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context. BMJ Open 3(8), 2013. e-Pub 2013. PMID: 23929922.
142. Pinto-Patarroyo GP, Rytting ME, Vierling JM, Suarez-Almazor ME. Haemophagocytic lymphohistiocytosis presenting as liver failure following Epstein-Barr and prior hepatitis A infections. BMJ Case Rep 2013, 2013. e-Pub 2013. PMID: 23943807.
143. Hwang JP, Fisch MJ, Lok AS, Zhang H, Vierling JM, Suarez-Almazor ME. Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. BMC Cancer 13(1):534, 2013. e-Pub 2013. PMID: 24209764.
144. Rader T, Pardo Pardo J, Stacey D, Ghogomu E, Maxwell LJ, Welch VA, Singh JA, Buchbinder R, Légaré F, Santesso N, Toupin April K, O'Connor AM, Wells GA, Winzenberg TM, Johnston R, Tugwell P. Cochrane Musculoskeletal Group Editors. Update of strategies to translate evidence from cochrane musculoskeletal group systematic reviews for use by various audiences. J Rheumatol. e-Pub 2013. PMID: 24293571.
145. Hwang JP, Roundtree AK, Giralt SA, Suarez-Almazor M. Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study. BMJ Support Palliat Care 2(4):344-50, 2012. e-Pub 2012. PMID: 24654219.
146. Gonzalez-Lopez L, Gamez-Nava JI, Vega-Lopez A, Rodriguez-Jimenez NA, Gonzalez-Montoya N, Aguilar-Chavez E, Alcaraz-Lopez MF, Rocha-Muñoz AD, Castro-Lizano N, Morales-Romero J, Salazar-Paramo M, Suarez-Almazor ME.. Performance of risk indices for identifying low bone mineral density and osteoporosis in mexican mestizo women with rheumatoid arthritis. J Rheumatol 39(2):247-53, 2012. PMID: 22174197.
147. Thombs BD, Jewett LR, Assassi S, Baron M, Bartlett SJ, Maia AC, El-Baalbaki G, Furst DE, Gottesman K, Haythornthwaite JA, Hudson M, Impens A, Korner A, Leite C, Mayes MD, Malcarne VL, Motivala SJ, Mouthon L, Nielson WR, Plante D, Poiraudeau S, Poole JL, Pope J, Sauve M, Steele RJ, Suarez-Almazor ME, Taillefer S, van den Ende CH, Arthurs E, Bassel M, Delisle V, Milette K, Leavens A, Razykov I, Khanna D. New directions for patient-Centred care in scleroderma: the Scleroderma Patient-centered Intervention Network (SPIN). Clin Exp Rheumatol 30(2 Suppl 71):S23-9, 2012. e-Pub 2012. PMID: 22244687.
148. Hwang JP, Roundtree AK, Suarez-Almazor ME. Attitudes toward hepatitis B virus among Vietnamese, Chinese and Korean Americans in the Houston Area, Texas. J Community Health 37(5):1091-100, 2012. PMID: 22302653.
149. Lopez-Olivo MA, Andrabi TR, Palla SL, Suarez-Almazor ME. Cervical spine radiographs in patients with rheumatoid arthritis undergoing anesthesia. J Clin Rheumatol 18(2):61-6, 2012. PMID: 22334269.
150. Jones CA, Cox V, Jhangri GS, Suarez-Almazor ME. Delineating the impact of obesity and its relationship on recovery after total joint arthroplasties. Osteoarthritis Cartilage 20(6):511-518, 2012. PMID: 22395039.
151. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG. 2012 update of the 2008 american college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64(5):625-39, 2012. PMID: 22473917.
152. Marengo MF, Waimann CA, de Achaval S, Zhang H, Garcia-Gonzalez A, Richardson MN, Reveille JD, Suarez-Almazor ME. Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring. Lupus 21(11):1158-65, 2012. e-Pub 2012. PMID: 22588588.
153. Ng B, Aslam F, Petersen NJ, Yu HJ, Suarez-Almazor ME. Identification of rheumatoid arthritis patients using an administrative database: A veterans affairs study. Arthritis Care Res (Hoboken) 64(10):1490-6, 2012. e-Pub 2012. PMID: 22623324.
154. Lu H, Marengo MF, Mihu CN, Garcia-Manero G, Suarez-Almazor ME. Rare case of septic arthritis caused by candida krusei: Case report and literature review. J Rheumatol 39(6):1308-9, 2012. PMID: 22661427.
155. Holmes HM, Luo R, Hanlon JT, Elting LS, Suarez-Almazor M, Goodwin JS. Ethnic disparities in adherence to antihypertensive medications of medicare Part D beneficiaries. J Am Geriatr Soc 60(7):1298-303, 2012. e-Pub 2012. PMID: 22702464.
156. Amezaga Urruela M, Suarez-Almazor ME. Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies. Curr Rheumatol Rep 14(5):428-37, 2012. e-Pub 2012. PMID: 22802154.
157. Street RL, Cox V, Kallen MA, Suarez-Almazor ME. Exploring communication pathways to better health: Clinician communication of expectations for acupuncture effectiveness. Patient Educ Couns 89(2):245-51, 2012. e-Pub 2012. PMID: 22857778.
158. Lopez-Olivo MA, Tayar JH, Martinez-Lopez JA, Pollono EN, Cueto JP, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA 308(9):898-908, 2012. PMID: 22948700.
159. Lopez-Olivo MA, Shah NA, Pratt G, Risser JM, Symanski E, Suarez-Almazor ME. Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis. Support Care Cancer 20(11):2985-98, 2012. e-Pub 2012. PMID: 22956190.
160. Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME. Febuxostat for treating chronic gout. Cochrane Database Syst Rev 11:CD008653, 2012. e-Pub 2012. PMID: 23152264.
161. Amezaga Urruela M, Suarez-Almazor ME. Acupuncture in the treatment of rheumatic diseases. Curr Rheumatol Rep 14(6):589-97, 2012. PMID: 23055010.
162. Hwang JP, Fisch MJ, Zhang H, Kallen MA, Routbort MJ, Lal LS, Vierling JM, Suarez-Almazor ME. Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract 8(4):e32-9, 2012. e-Pub 2012. PMID: 23180996.
163. de Achaval S, Fraenkel L, Volk RJ, Cox V, Suarez-Almazor ME. Impact of educational and patient decision aids on decisional conflict associated with total knee arthroplasty. Arthritis Care Res (Hoboken) 64(2):229-37, 2012. PMID: 21954198.
164. Gossec L, Paternotte S, Maillefert JF, Combescure C, Conaghan PG, Davis AM, Gunther KP, Hawker G, Hochberg M, Katz JN, Kloppenburg M, Lim K, Lohmander LS, Mahomed NN, March L, Pavelka K, Punzi L, Roos EM, Sanchez-Riera L, Singh JA, Suarez-Almazor ME, Dougados M, OARSI-OMERACT Task Force "total articular replacement as outcome measure in OA". The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: An international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage 19(2):147-54, 2011. PMID: 21044689.
165. Roundtree AK, Giordano SH, Price A, Suarez-Almazor ME. Problems in transition and quality of care: perspectives of breast cancer survivors. Support Care Cancer 19(12):1921-9, 2011. e-Pub 2010. PMID: 21140173.
166. Naik AD, Palmer N, Peersen NJ, Street RL, Rao R, Suarez-Almazor M, Haidet P. Comparative effectiveness of goal setting in diabetes mellitus group clinics: randomized clinical trial. Arch Intern Med 171(5):453-9, 2011. PMID: 21403042.
167. Naqvi K, Garcia-Manero G, Sardesai S, Oh J, Vigil CE, Pierce S, Lei X, Shan J, Kantarjian HM, Suarez-Almazor ME. Association of cmorbidities with overall survival in myelodysplastic syndrome: Development of a prognostic model. J Clin Oncol 29(16):2240-6, 2011. PMID: 21537048.
168. Lopez-Olivo MA, Landon GC, Siff SJ, Edelstein D, Pak C, Kallen MA, Stanley M, Zhang H, Robinson KC, Suarez-Almazor ME.. Psychosocial determinants of outcomes in knee replacement. Ann Rheum Dis 70(10):1775-81, 2011. PMID: 21791452.
169. Gossec L, Paternotte S, Bingham CO, Clegg DO, Coste P, Conaghan PG, Davis AM, Giacovelli G, Gunther KP, Hawker G, Hochberg MC, Jordan JM, Katz JN, Kloppenburg M, Lanzarotti A, Lim K, Lohmander LS, Mahomed NN, Maillefert JF, Manno RL, March LM, Mazzuca SA, Pavelka K, Punzi L, Roos EM, Rovati LC, Shi H, Singh JA, Suarez-Almazor ME, Tajana-Messi E, Dougados M, For the OARSI-OMERACT Task Force Total Articular Replacement as Outcome Measure in OA. OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol 38(8):1765-9, 2011. PMID: 21807799.
170. Suarez-Almazor ME, Richardson M, Kroll TL, Sharf BF. A qualitative analysis of decision-making for total knee replacement in patients with osteoarthritis. J Clin Rheumatol 16(4):158-63, 2010. PMID: 20414128.
171. Suarez-Almazor ME, Looney C, Liu Y, Cox V, Pietz K, Marcus DM, Street RL. A randomized controlled trial of acupuncture for osteoarthritis of the knee: Effects of patient-provider communication. Arthritis Care Res (Hoboken) 62(9):1229-36, 2010. PMID: 20506122.
172. Pollono EN, Madoff DC, Spence SC, Suarez-Almazor ME. Multiple hepatic artery aneurysms in a patient with systemic lupus erythematosus. Lupus 19(1):93-5, 2010. PMID: 19884215.
173. Hwang JP, Roundtree AK, Engebretson JC, Suarez-Almazor ME. Medical Care of Hepatitis B among Asian American Populations: Perspectives from Three Provider Groups. J Gen Intern Med 25(3):220-7, 2010. e-Pub 2010. PMID: 20049549.
174. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev(4):CD007848, 2010. PMID: 19821440.
175. de Achaval S, Suarez-Almazor ME. Treatment adherence to disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and systemic Lupus erythematosus. Int J Clin Rheumtol 5(3):313-326, 2010. PMID: 20676388.
176. Kallen MA, Mayes MD, Kriseman YL, de Achaval SB, Cox VL, Suarez-Almazor ME. The symptom burden index: development and initial findings from use with patients with systemic sclerosis. J Rheumatol 37(8):1692-8, 2010. e-Pub 2010. PMID: 20516027.
177. Pollono EN, Lopez-Olivo MA, Lopez JA, Suarez-Almazor ME. A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol 29(9):947-55, 2010. e-Pub 2010. PMID: 20383550.
178. Weisman MH, Chen L, Clegg DO, Davis JC, Dubois RW, Prete PE, Savage LM, Schafer L, Suarez-Almazor ME, Yu HT, Reveille JD. Development and validation of a case ascertainment tool for ankylosing spondylitis. Arthritis Care Res (Hoboken) 62(1):19-27, 2010. PMID: 20191487.
179. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Ghogomu ET, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Sao Paulo Med J 128(5):309-10, 2010. PMID: 21181074.
180. Garcia-Gonzalez A, Gonzalez-Lopez L, Gamez-Nava JI, Rodríguez-Arreola BE, Cox V, Suarez-Almazor ME. Doctor-patient interactions in Mexican patients with rheumatic disease. J Clin Rheumatol 15(3):120-3, 2009. PMID: 19300289.
181. Street RL Jr, Richardson MN, Cox V, Suarez-Almazor ME. (Mis)understanding in patient-health care provider communications about total knee replacement. Arthritis Rheum 61(1):100-107, 2009. PMID: 19116969.
182. Roundtree AK, Kallen MA, Lopez-Olivo MA, Kimmel B,Skidmore B, Ortiz Z, Cox V, Suarez-Almazor ME. Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: a systematic review. J Clin Epidemiol 62(2):128-37, 2009. PMID: 19013763.
183. Massardo L, Suárez-Almazor ME, Cardiel MH, Nava A, Levy RA, Laurindo I, Soriano ER, Acevedo-Vázquez E, Millán A, Pineda-Villaseñor C, Galarza-Maldonado C, Caballero-Uribe CV, Espinosa-Morales R, Pons-Estel BA. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide. J Clin Rheumatol 15(4):203-10, 2009. PMID: 19502907.
184. Kirwan JR, Newman S, Tugwell PS, Wells GA, Hewlett S, Idzera L, Laslo B, March LM, Minnock P, Montie P, Nicklin J, Rader T, Richards P, Sanderson TC, Suarez-Almazor M, Tanjong-Ghogomu E, Ueffing E, Welch V. Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9. J Rheumatol 36(9):2071-6, 2009. PMID: 19738216.
185. Boonen A, Maetzel A, Drummond M, Suarez-Almazor M, Harrison M, Welch V, Tugwell PS. The OMERACT Initiative. Towards a reference approach to derive QALY for economic evaluations in rheumatology. J Rheumatol 36(9):2045-9, 2009. PMID: 19738211.
186. Wells GA, Li T, Kirwan JR, Peterson J, Aletaha D, Boers M, Bresnihan B, Dougados M, Idzerda L, Nicklin J, Suarez-Almazor M, Welch V, Tugwell PS. Assessing quality of sleep in patients with rheumatoid arthritis. J Rheumatol 36(9):2077-86, 2009. PMID: 19738217.
187. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Ghogomu ET, Tugwell P. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ 181(11):787-96, 2009. PMID: 19884297.
188. Hawker GA, Stewart L, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Gooberman-Hill R. Understanding the pain experience in hip and knee osteoarthritis--an OARSI/OMERACT initiative. Osteoarthritis Cartilage 16(4):415-22, 2008. PMID: 18296075.
189. Hawker GA, Davis AM, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Katz JN, Dieppe P. Development and preliminary psychometric testing of a new OA pain measure--an OARSI/OMERACT initiative. Osteoarthritis Cartilage 16(4):409-14, 2008. PMID: 18381179.
190. Gossec L, Jordan JM, Mazzuca SA, Lam MA, Suarez-Almazor ME, Renner JB, Lopez-Olivo MA, Hawker G, Dougados M, Maillefert JF, Maillefert JF. Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT task force Extended report. Osteoarthritis Cartilage 16(7):742-8, 2008. PMID: 18417373.
191. Garcia-Gonzalez A, Richardson M, Garcia Popa-Lisseanu M, Cox V, Kallen MA, Janssen N, Ng B, Marcus DM, Reveille JD, Suarez-Almazor ME. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 27(7):883-9, 2008. PMID: 18185905.
192. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Suarez Almazor M, Bridges SL, Chatham WW, Hochberg M, MacLean C, Mikuls T, Moreland LW, O'Dell J, Turkiewicz AM, Furst DE, Furst DE. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59(6):762-84, 2008. PMID: 18512708.
193. Lopez-Olivo MA, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: A systematic review. Arthritis Rheum 59(11):1625-1638, 2008. PMID: 18975351.
194. Tugwell P, Maxwell L, Welch V, Kristjansson E, Petticrew M, Wells G, Buchbinder R, Suarez-Almazor ME, Nowlan MA, Ueffing E, Khan M, Shea B, Tsikata S. Is health equity considered in systematic reviews of the cochrane musculoskeletal group?. Arthritis Rheum 59(11):1603-1610, 2008. PMID: 18975366.
195. Kroll TL, Richardson M, Sharf BF, Suarez-Almazor ME. "Keep on truckin'" or "It's got you in this little vacuum": race-based perceptions in decision-making for total knee arthroplasty. J Rheumatol 34(5):1069-75, 2007. PMID: 17407213.
196. Kelly PA, Kallen MA, Suárez-Almazor ME. A combined-method psychometric analysis recommended modification of the multidimensional health locus of control scales. J Clin Epidemiol 60(5):440-7, 2007. PMID: 17419954.
197. Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, Hazes M, Richards P, Saag K, Suarez-Almazor M, Wells G, Hewlett S. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 34(5):1174-7, 2007. PMID: 17477482.
198. Kane RL, Wilt T, Suarez-Almazor ME, Fu SS. Disparities in total knee replacements: a review. Arthritis Rheum 57(4):562-7, 2007. PMID: 17471555.
199. Giordano TP, Gifford AL, White AC, Suarez-Almazor ME, Rabeneck L, Hartman C, Backus LI, Mole LA, Morgan RO. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis 44(11):1493-9, 2007. PMID: 17479948.
200. Gossec L, Hawker G, Davis AM, Maillefert JF, Lohmander LS, Altman R, Cibere J, Conaghan PG, Hochberg MC, Jordan JM, Katz JN, March L, Mahomed N, Pavelka K, Roos EM, Suarez-Almazor ME, Zanoli G, Dougados M. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. J Rheumatol 34(6):1432-5, 2007. PMID: 17552070.
201. Collins TC, Beyth RJ, Nelson DB, Petersen NJ, Suarez-Almazor ME, Bush RL, Hirsch AT, Ashton CM. Process of care and outcomes in patients with peripheral arterial disease. J Gen Intern Med 22(7):942-8, 2007. PMID: 17453264.
202. Suarez-Almazor ME, Kallen MA, Roundtree AK, Mayes M. Disease and symptom burden in systemic sclerosis: a patient perspective. J Rheumatol 34(8):1718-26, 2007. PMID: 17611983.
203. Lopez-Olivo MA, Suarez-Almazor ME. Developing guidelines in musculoskeletal disorders. Clin Exp Rheumatol 25(6 Suppl 47):28-36, 2007. PMID: 18021504.
204. Suarez-Almazor ME, Berrios-Rivera JP, Cox V, Janssen NM, Marcus DM, Sessoms S. Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis. J Rheumatol 34(12):2400-7, 2007. PMID: 17985405.
205. Jones CA, Beaupre LA, Johnston DW, Suarez-Almazor ME. Total joint arthroplasties: Current concepts of patients outcomes after surgery. Rheum Dis Clin North Am 33(1):71-86, 2007. PMID: 17367693.
206. Collins TC, Suarez-Almazor M, Peterson NJ. An absent pulse is not sensitive for the early detection of peripheral arterial disease. Fam Med 38(1):38-42, 2006. PMID: 16378257.
207. Suarez-Almazor ME. Is treatment with pulsed electromagnetic fields effective in patients with knee osteoarthritis?. Nat Clin Pract Rheumatol 2(1):14-5, 2006. PMID: 16932645.
208. Collins TC, Suarez-Almazor M, Bush RL, Petersen NJ. Gender and peripheral arterial disease. J Am Board Fam Med 19(2):132-40, 2006. PMID: 16513901.
209. Giordano TP, Morgan RO, Kramer JR, Hartman C, Richardson P, White CA, Suarez-Almazor ME, El-Serag HB. Is there a race-based disparity in the survival of veterans with HIV?. Gen Intern Med 21(6):613-7, 2006. PMID: 16808745.
210. Berrios-Rivera JP, Street RL, Garcia Popa-Lisseanu MG, Kallen MA, Richardson MN, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 55(3):385-93, 2006. PMID: 16739207.
211. Byrne MM, Souchek J, Richardson M, Suarez-Almazor M. Racial/ethnic differences in preferences for total knee replacement surgery. J Clin Epidemiol 59(10):1078-86, 2006. PMID: 16980148.
212. Chiou CF, Suarez-Almazor ME, Sherbourne CD, Chang CH, Reyes C, Dylan M, Ofman J, Wallace DJ, Mizutani W, Weisman M. Development and validation of a preference weight multiattribute health outcome measure for rheumatoid arthritis. J Rheumatol 33(12):2409-11, 2006. PMID: 17080516.
213. Maxwell L, Santesso N, Tugwell PS, Judd M, Buchbinder. Method guidelines for Cochrane Musculoskeletal Group systematic reviews. J Rheumatol 33(11):2304-11, 2006. PMID: 17086611.
214. Santesso N, Maxwell L, Tugwell PS, Wells GA, O'connor AM, Judd M, Buchbinder R. Knowledge transfer to clinicians and consumers by the Cochrane Musculoskeletal Group. J Rheumatol 33(11):2312-8, 2006. PMID: 17086612.
215. Santesso N, Maxwell L, Tugwell PS, Buchbinder R, Johnston R, the Editorial Board of the Cochrane Musculoskeletal Group. Systematic reviews from the cochrane musculoskeletal group. J Can Chiropr Assoc 50(4):238-43, 2006. PMID: 17549183.
216. Collins TC, Petersen NJ, Suarez-Almazor M, Ashton CM. Ethnicity and peripheral arterial disease. Mayo Clin Proc 80(1):48-54, 2005. PMID: 15667029.
217. Garcia Popa-Lisseanu MG, Greisinger A, Richardson M, O'Malley KJ, Janssen NM, Marcus DM, Tagore J, Suarez-Almazor ME. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 32(5):913-9, 2005. PMID: 15868630.
218. Suarez-Almazor ME, Souchek J, Kelly PA, O'Malley K, Byrne M, Richardson M, Pak C. Ethnic variation in knee replacement: patient preferences or uninformed disparity?. Arch Intern Med 165(10):1117-24, 2005. PMID: 15911724.
219. Collins TC, Petersen NJ, Suarez-Almazor M. Peripheral arterial disease symptom subtype and walking impairment. Vasc Med 10(3):177-83, 2005. PMID: 16235770.
220. Souchek J, Byrne MM, Kelly PA, O' Malley K, Richardson M, Pak C, Nelson H, Suarez-Almazor ME. Valuation of arthritis health states across ethnic groups and between patients and community members. Med Care 43(9):921-8, 2005. PMID: 16116357.
221. Eason SL, Petersen NJ, Suarez-Almazor M, Davis B, Collins TC. Diabetes mellitus, smoking, and the risk for asymptomatic peripheral arterial disease: whom should we screen?. J Am Board Fam Pract 18(5):355-61, 2005. PMID: 16148245.
222. Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, Aletaha D, Anderson JJ, Bombardier C, Dougados M, Emery P, Felson DT, Fransen J, Furst DE, Hazes JM, Johnson KR, Kirwan JR, Landewé RB, Lassere MN, Michaud K, Suarez-Almazor M, Silman AJ, Smolen JS, Van der Heijde DM, van Riel PL, Wolfe F, Tugwell PS. Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol 32(10):2016-24, 2005. PMID: 16206362.
223. Byrne MM, O'malley K, Suarez-Almazor ME. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis. Med Decis Making 25(6):655-66, 2005. PMID: 16282216.
224. Giordano TP, Suarez-Almazor ME, Grimes RM. The population effectiveness of highly active antiretroviral therapy: are good drugs good enough?. Curr HIV/AIDS Rep 2(4):177-83, 2005. PMID: 16343375.
225. Chiou CF, Weisman M, Sherbourne CD, Reyes C, Dylan M, Ofman J, Wallace DJ, Mizutani W, Suarez-Almazor ME. Measuring preference weights for American College of Rheumatology response criteria for patients with rheumatoid arthritis. J Rheumatol 32(12):2326-9, 2005. PMID: 16331757.
226. Moffett ML, Suarez-Almazor ME. Prospect theory in the valuation of health. Expert Rev. Pharmacoecon. Outcomes Res. 5(4):499-505, 2005. PMID: 19807267.
227. Collins TC, O'Malley KJ, Peterson NJ, Suarez-Almazor ME. The Lifestyle and Clinical Survey: A Medical History Questionnaire. Fed Pract 22(5):25-26, 29-32, 38-46, 2005.
228. Roorda LD, Jones CA, Waltz M, Lankhorst GJ, Bouter LM, van der Eijken JW, Willems WJ, Heyligers IC, Voaklander DC, Kelly KD, Suarez-Almazor ME. Satisfactory cross cultural equivalence of the Dutch WOMAC in patients with hip osteoarthritis waiting for arthroplasty. Ann Rheum Dis 63(1):36-42, 2004. PMID: 14672889.
229. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, Woo P. International League of Associations for Rheumatology (ILAR) classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390-2, 2004. PMID: 14760812.
230. Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 50(2):400-12, 2004. PMID: 14872482.
231. Homik JE, Suarez-Almazor M. An economic approach to health care. Best Pract Res Clin Rheumatol 18(2):203-18, 2004. PMID: 15121040.
232. Vigano A, Donaldson N, Higginson IJ, Bruera E, Mahmud S, Suarez-Almazor M. Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer 101(5):1090-8, 2004. PMID: 15329920.
233. Byrne MM, O'Malley KJ, Suarez-Almazor ME. Ethnic differences in health preferences: analysis using willingness-to-pay. J Rheumatol 31(9):1811-8, 2004. PMID: 15338505.
234. Collins TC, Suarez-Almazor M, Petersen NJ, O'Malley KJ. A Spanish translation of the Walking Impairment Questionnaire was validated for patients with peripheral arterial disease. J Clin Epidemiol 57(12):1305-15, 2004. PMID: 15617957.
235. Jones CA, Voaklander DC, Suarez-Almazor ME. Determinants of function after total knee arthroplasty. Phys Ther 83(8):696-706, 2003. PMID: 12882610.
236. Osiri M, Shea B, Robinson V, Suarez-Almazor M, Strand V, Tugwell P, Wells G. Leflunomide for treating rheumatoid arthritis. Cochrane Database Syst Rev(1):CD002047, 2003. PMID: 12535423.
237. Ashton CM, Haidet P, Paterniti DA, Collins TC, Gordon HS, O'Malley K, Petersen LA, Sharf BF, Suarez-Almazor ME, Wray NP, Street RL. Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication?. J Gen Intern Med 18(2):146-52, 2003. PMID: 12542590.
238. O'Malley KJ, Suarez-Almazor M, Aniol J, Richardson P, Kuykendall DH, Moseley JB, Wray NP. Joint-specific multidimensional assessment of pain (J-MAP): factor structure, reliability, validity, and responsiveness in patients with knee osteoarthritis. J Rheumatol 30(3):534-43, 2003. PMID: 12610814.
239. Osiri M, Suarez-Almazor ME, Wells GA, Robinson V, Tugwell P. Number needed to treat (NNT): implication in rheumatology clinical practice. Ann Rheum Dis 62(4):316-21, 2003. PMID: 12634229.
240. Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, Ahlmèn M, Boers M, Minnock P, Saag K, Shea B, Suarez Almazor M, Taal E. Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol 30(4):868-72, 2003. PMID: 12672218.
241. Osiri M, Shea B, Robinson V, Suarez-Almazor M, Strand V, Tugwell P, Wells G. Leflunomide for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol 30(6):1182-90, 2003. PMID: 12784387.
242. Badamgarav E, Croft JD, Hohlbauch A, Louie JS, O'Dell J, Ofman JJ, Suarez-Almazor ME, Weaver A, White P, Katz P, Katz P. Effects of disease management programs on functional status of patients with rheumatoid arthritis. Arthritis Rheum 49(3):377-87, 2003. PMID: 12794794.
243. Collins TC, Petersen NJ, Suarez-Almazor M, Ashton CM. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med 163(12):1469-74, 2003. PMID: 12824097.
244. Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care 41(7):791-801, 2003. PMID: 12835603.
245. Merkel PA, Clements PJ, Reveille JD, Suarez-Almazor ME, Valentini G, Furst DE, Furst DE. Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol 30(7):1630-47, 2003. PMID: 12858472.
246. Weisman MH, Gano AD, Gabriel SE, Hochberg MC, Kavanaugh A, Ofman JJ, Prashker M, Suarez-Almazor ME, Yelin E, Nakelsky SD, Croft JD, Croft JD. Reading and interpreting economic evaluations in rheumatoid arthritis: an assessment of selected instruments for critical appraisal. J Rheumatol 30(8):1739-47, 2003. PMID: 12913929.
247. Suarez-Almazor ME, Drummond M. Regulatory issues and economic efficiency. J Rheumatol Suppl 68:5-7, 2003. PMID: 14712614.
248. Emery P, Suarez-Almazor ME. Rheumatoid arthritis. Am Fam Physician 68(9):1821-3, 2003. PMID: 14620602.
249. Suarez-Almazor ME. In quest of the holy grail: efficacy versus effectiveness in rheumatoid arthritis. J Rheumatol 29(2):209-11, 2002. PMID: 11838836.
250. Suarez-Almazor ME, Newman C, Hanson J, Bruera E. Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival. J Clin Oncol 20(8):2134-41, 2002. PMID: 11956275.
251. Suarez-Almazor ME. Unraveling gender and ethnic variation in the utilization of elective procedures: the case of total joint replacement. Med Care 40(6):447-50, 2002. PMID: 12021670.
252. Kelly KD, Voaklander DC, Johnston WC, Suarez-Almazor ME. Equity in waiting times for major joint arthroplasty. Can J Surg 45(4):269-76, 2002. PMID: 12174981.
253. Maksymowych WP, Suarez-Almazor ME, Buenviaje H, Cooper BL, Degeus C, Thompson M, Russell AS. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis. J Rheumatol 29(11):2319-26, 2002. PMID: 12415587.
254. Suarez-Almazor ME, Kendall CJ, Dorgan M. Surfing the Net-information on the World Wide Web for persons with arthritis: patient empowerment or patient deceit?. J Rheumatol 28(1):185-91, 2001. PMID: 11196523.
255. Cree M, Hayduk L, Soskolne CL, Suarez-Almazor M. Modeling changes in health perception following hip fracture. Qual Life Res 10(8):651-9, 2001. PMID: 11871586.
256. Jones CA, Voaklander DC, Johnston DW, Suarez-Almazor ME. The effect of age on pain, function, and quality of life after total hip and knee arthroplasty. Arch Intern Med 161(3):454-60, 2001. PMID: 11176772.
257. Suarez-Almazor ME, Conner-Spady B. Rating of arthritis health states by patients, physicians, and the general public. Implications for cost-utility analyses. J Rheumatol 28(3):648-56, 2001. PMID: 11296976.
258. Gabriel S, Drummond M, Suarez-Almazor ME, Ruff B, Guillemin F, Bombardier C, Boers M, Maetzel A, Ruof J, Cranney A, Marentette M, Tugwell P. OMERACT 5 Economics Working Group: summary, recommendations, and research agenda. J Rheumatol 28(3):670-3, 2001. PMID: 11296980.
259. Suarez-Almazor ME, Conner-Spady B, Kendall CJ, Russell AS, Skeith K. Lack of congruence in the ratings of patients' health status by patients and their physicians. Med Decis Making 21(2):113-21, 2001. PMID: 11310944.
260. Kelly KD, Voaklander DC, Johnston DW, Newman SC, Suarez-Almazor ME. Change in pain and function while waiting for major joint arthroplasty. J Arthroplasty 16(3):351-9, 2001. PMID: 11307134.
261. Cree M, Carriere KC, Soskolne CL, Suarez-Almazor M. Functional dependence after hip fracture. Am J Phys Med Rehabil 80(10):736-43, 2001. PMID: 11562555.
262. Marcus DM, Suarez-Almazor ME. Is there a role for ginger in the treatment of osteoarthritis?. Arthritis Rheum 44(11):2461-2, 2001. PMID: 11710700.
263. Viganò A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 14(5):363-74, 2000. PMID: 11064783.
264. Suarez-Almazor ME, Belseck E, Homik J, Dorgan M, Ramos-Remus C. Identifying clinical trials in the medical literature with electronic databases: MEDLINE alone is not enough. Control Clin Trials 21(5):476-87, 2000. PMID: 11018564.
265. Kelly KD, Voaklander D, Kramer G, Johnston DW, Redfern L, Suarez-Almazor ME. The impact of health status on waiting time for major joint arthroplasty. J Arthroplasty 15(7):877-83, 2000. PMID: 11061448.
266. Tugwell P, Welch V, Suarez-Almazor M, Shea B, Wells G. Efficacy and toxicity of old and new disease modifying antirheumatic drugs. Ann Rheum Dis 59 Suppl 1:i32-5, 2000. PMID: 11053083.
267. Homik JE, Suarez-Almazor ME. Clinical guidelines: a must for rheumatology?. Baillieres Best Pract Res Clin Rheumatol 14(4):649-61, 2000. PMID: 11092794.
268. Gonzalez-Lopez L, Gamez-Nava JI, Jhangri G, Russell AS, Suarez-Almazor ME. Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. J Rheumatol 27(1):41-6, 2000. PMID: 10648016.
269. Maksymowych WP, Tao S, Vaile J, Suarez-Almazor M, Ramos-Remus C, Russell AS. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis. J Rheumatol 27(1):183-9, 2000. PMID: 10648037.
270. Clark P, Tugwell P, Bennet K, Bombardier C, Shea B, Wells G, Suarez-Almazor ME. Injectable gold for rheumatoid arthritis. Cochrane Database Syst Rev(2):CD000520, 2000. PMID: 10796386.
271. Ortiz Z, Shea B, Suarez Almazor M, Moher D, Wells G, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev(2):CD000951, 2000. PMID: 10796393.
272. Homik J, Suarez-Almazor ME, Shea B, Cranney A, Wells G, Tugwell P. Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev(2):CD000952, 2000. PMID: 10796394.
273. Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev(2):CD000957, 2000. PMID: 10796399.
274. Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Sulfasalazine for rheumatoid arthritis. Cochrane Database Syst Rev(2):CD000958, 2000. PMID: 10796400.
275. Suarez-Almazor ME, Belseck E, Shea B, Homik J, Wells G, Tugwell P. Antimalarials for rheumatoid arthritis. Cochrane Database Syst Rev(2):CD000959, 2000. PMID: 10796401.
276. Wells G, Haguenauer D, Shea B, Suarez-Almazor ME, Welch VA, Tugwell P. Cyclosporine for rheumatoid arthritis. Cochrane Database Syst Rev(2):CD001083, 2000. PMID: 10796412.
277. Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Cyclophosphamide for rheumatoid arthritis. Cochrane Database Syst Rev(2):CD001157, 2000. PMID: 10796419.
278. Criswell LA, Saag KG, Sems KM, Welch V, Shea B, Wells G, Suarez-Almazor ME. Moderate-term, low-dose corticosteroids for rheumatoid arthritis. Cochrane Database Syst Rev(2):CD001158, 2000. PMID: 10796420.
279. Homik J, Cranney A, Shea B, Tugwell P, Wells G, Adachi R, Suarez-Almazor M. Bisphosphonates for steroid induced osteoporosis. Cochrane Database Syst Rev(2):CD001347, 2000. PMID: 10796432.
280. Cranney A, Welch V, Adachi JD, Homik J, Shea B, Suarez-Almazor ME, Tugwell P, Wells G. Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis. Cochrane Database Syst Rev(2):CD001983, 2000. PMID: 10796457.
281. Suarez-Almazor ME, Spooner CH, Belseck E, Shea B. Auranofin versus placebo in rheumatoid arthritis. Cochrane Database Syst Rev(2):CD002048, 2000. PMID: 10796461.
282. Suarez-Almazor ME, Belseck E, Shea B, Homik J, Wells G, Tugwell P. Antimalarials for treating rheumatoid arthritis. Cochrane Database Syst Rev(4):CD000959, 2000. PMID: 11034691.
283. Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Cyclophosphamide for treating rheumatoid arthritis. Cochrane Database Syst Rev(4):CD001157, 2000. PMID: 11034702.
284. Suarez-Almazor ME, Spooner C, Belseck E. Penicillamine for treating rheumatoid arthritis. Cochrane Database Syst Rev(4):CD001460, 2000. PMID: 11034719.
285. Cree M, Soskolne CL, Belseck E, Hornig J, McElhaney JE, Brant R, Suarez-Almazor M. Mortality and institutionalization following hip fracture. J Am Geriatr Soc 48(3):283-8, 2000. PMID: 10733054.
286. Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME, Bruera ED. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 160(6):786-94, 2000. PMID: 10737278.
287. Viganó A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME. Clinical survival predictors in patients with advanced cancer. Arch Intern Med 160(6):861-8, 2000. PMID: 10737287.
288. Suarez-Almazor ME, Kendall C, Johnson JA, Skeith K, Vincent D. Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments. Rheumatology (Oxford) 39(7):783-90, 2000. PMID: 10908699.
289. Jones CA, Voaklander DC, Johnston DW, Suarez-Almazor ME. Health related quality of life outcomes after total hip and knee arthroplasties in a community based population. J Rheumatol 27(7):1745-52, 2000. PMID: 10914862.
290. Esdaile JM, Koehler BE, Suarez-Almazor ME, et al. Canadian Consensus Conference on hydroxychloroquine. J Rheumatol 27(12):2919-21, 2000. PMID: 11128686.
291. Suarez-Almazor ME, Spooner C, Belseck E. Azathioprine for treating rheumatoid arthritis. Cochrane Database Syst Rev(4):CD001461, 2000. PMID: 11034720.
292. Suarez-Almazor ME, Spooner C, Belseck E. Azathioprine for rheumatoid arthritis. Cochrane Database Syst Rev(2):CD001461, 2000. PMID: 10796441.
293. Suarez-Almazor ME, Spooner C, Belseck E. Penicillamine for rheumatoid arthritis. Cochrane Database Syst Rev(2):CD001460, 2000. PMID: 10796440.
294. Wong JH, Lubkey TB, Suarez-Almazor ME, Findlay JM. Improving the appropriateness of carotid endarterectomy: results of a prospective city-wide study. Stroke 30(1):12-5, 1999. PMID: 9880381.
295. Suarez-Almazor ME, Kaul P, Kendall CJ, Saunders LD, Johnston DW. The cost-effectiveness of magnetic resonance imaging for patients with internal derangement of the knee. Int J Technol Assess Health Care 15(2):392-405, 1999. PMID: 10507197.
296. Viganò A, Bruera E, Suarez-Almazor ME. Terminal cancer syndrome: myth or reality?. J Palliat Care 15(4):32-9, 1999. PMID: 10693304.
297. Wolfe F, Lassere M, van der Heijde D, Stucki G, Suarez-Almazor M, Pincus T, Eberhardt K, Kvien TK, Symmons D, Silman A, van Riel P, Tugwell P, Boers M. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 26(2):484-9, 1999. PMID: 9972992.
298. Gonzalez-Lopez L, Gamez-Nava JI, Jhangri GS, Ramos-Remus C, Russell AS, Suarez-Almazor ME. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. J Rheumatol 26(3):540-5, 1999. PMID: 10090159.
299. Major P, Ramos-Remus C, Suarez-Almazor ME, Hatcher D, Parfitt M, Russell AS. Magnetic resonance imaging and clinical assessment of temporomandibular joint pathology in ankylosing spondylitis. J Rheumatol 26(3):616-21, 1999. PMID: 10090172.
300. Homik JE, Cranney A, Shea B, Tugwell P, Wells G, Adachi JD, Suarez-Almazor ME. A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis. J Rheumatol 26(5):1148-57, 1999. PMID: 10332982.
301. Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM. Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 44(6):1237-47; discussion 1247-8, 1999. PMID: 10371622.
302. Viganò A, Dorgan M, Bruera E, Suarez-Almazor ME. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer 86(1):170-6, 1999. PMID: 10391577.
303. Rolfson DB, McElhaney JE, Rockwood K, Finnegan BA, Entwistle LM, Wong JF, Suarez-Almazor ME. Incidence and risk factors for delirium and other adverse outcomes in older adults after coronary artery bypass graft surgery. Can J Cardiol 15(7):771-6, 1999. PMID: 10411615.
304. Nekolaichuk CL, Maguire TO, Suarez-Almazor M, Rogers WT, Bruera E. Assessing the reliability of patient, nurse, and family caregiver symptom ratings in hospitalized advanced cancer patients. J Clin Oncol 17(11):3621-30, 1999. PMID: 10550162.
305. Galindo-Rodriguez G, Aviña-Zubieta JA, Russell AS, Suarez-Almazor ME. Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study. J Rheumatol 26(11):2337-43, 1999. PMID: 10555887.
306. Davis P, Andrews E, Donen N, Fitzgerald A, Hughes S, Juby A, Kvern B, Low S, Nixon O, Russell A, Skeith K, Suarez-Almazor M. Case studies in osteoporosis: a problem based learning intervention for family physicians. J Rheumatol 26(11):2418-22, 1999. PMID: 10555904.
307. Ramos-Remus C, Watters CA, Dyke L, Suarez-Almazor ME, Russell AS. Assessment of health locus of control in the use of nonconventional remedies by patients with rheumatic diseases. J Rheumatol 26(11):2468-74, 1999. PMID: 10555911.
308. Wells G, Boers M, Shea B, Tugwell P, Westhovens R, Suarez-Almazor M, Buchbinder R. Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for Rheumatology. J Rheumatol 26(1):217-21, 1999. PMID: 9918267.
309. Bruera E, Suarez-Almazor M. Cost effectiveness in palliative care. Palliat Med 12(5):315-316, 1998. PMID: 9924594.
310. Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol 25(1):36-43, 1998. PMID: 9458200.
311. Suarez-Almazor ME, Russell AS. The art versus the science of medicine. Are clinical practice guidelines the answer?. Ann Rheum Dis 57(2):67-9, 1998. PMID: 9613333.
312. Gamez-Nava JI, Gonzalez-Lopez L, Ramos-Remus C, Fonseca-Gomez MM, Cardona-Muñoz EG, Suarez-Almazor ME. Autonomic dysfunction in patients with systemic lupus erythematosus. J Rheumatol 25(6):1092-6, 1998. PMID: 9632069.
313. Ramos-Remus C, Russell AS, Gomez-Vargas A, Hernandez-Chavez A, Maksymowych WP, Gamez-Nava JI, Gonzalez-Lopez L, García-Hernández A, Meoño-Morales E, Burgos-Vargas R, Suarez-Almazor ME. Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis 57(7):429-33, 1998. PMID: 9797571.
314. Viganó A, Bruera E, Suarez-Almazor ME. Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 83(6):1244-50, 1998. PMID: 9740092.
315. Suarez-Almazor ME, Gonzalez-Lopez L, Gamez-Nava JI, Belseck E, Kendall CJ, Davis P. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians. J Rheumatol 25(10):1980-5, 1998. PMID: 9779854.
316. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25(10):1991-4, 1998. PMID: 9779856.
317. Ramos-Remus C, Gamez-Nava JI, Gonzalez-Lopez L, Skeith KJ, Perla-Navarro AV, Galvan-Villegas F, Suarez-Almazor ME. Use of alternative therapies by patients with rheumatic disease in Guadalajara, Mexico: prevalence, beliefs, and expectations. Arthritis Care Res 11(5):411-8, 1998. PMID: 9830886.
318. Aviña-Zubieta JA, Galindo-Rodriguez G, Newman S, Suarez-Almazor ME, Russell AS. Long-term effectiveness of antimalarial drugs in rheumatic diseases. Ann Rheum Dis 57(10):582-7, 1998. PMID: 9893568.
319. Gamez-Nava JI, Gonzalez-Lopez L, Davis P, Suarez-Almazor ME. Referral and diagnosis of common rheumatic diseases by primary care physicians. Br J Rheumatol 37(11):1215-9, 1998. PMID: 9851272.
320. Ramos-Remus C, Perez-Rocha O, Ludwig RN, Kolotyluk DR, Gomez-Vargas A, Suarez-Almazor ME, Russell AS. Magnetic resonance changes in the temporomandibular joint in ankylosing spondylitis. J Rheumatol 24(1):123-7, 1997. PMID: 9002022.
321. Suarez-Almazor ME, Belzile M, Bruera E. Euthanasia and physician-assisted suicide: a comparative survey of physicians, terminally ill cancer patients, and the general population. J Clin Oncol 15(2):418-27, 1997. PMID: 9053461.
322. Galindo-Rodriguez G, Avina-Zubieta JA, Fitzgerald A, LeClerq SA, Russell AS, Suarez-Almazor ME. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis. J Rheumatol 24(4):633-8, 1997. PMID: 9101493.
323. Wong JH, Findlay JM, Suarez-Almazor ME. Regional performance of carotid endarterectomy. Appropriateness, outcomes, and risk factors for complications. Stroke 28(5):891-8, 1997. PMID: 9158621.
324. Suarez-Almazor ME, Belseck E, Russell AS, Mackel JV. Use of lumbar radiographs for the early diagnosis of low back pain. Proposed guidelines would increase utilization. JAMA 277(22):1782-6, 1997. PMID: 9178791.
325. Suarez-Almazor M, Homik JE, Messina D, Davis P. Attitudes and beliefs of family physicians and gynecologists in relation to the prevention and treatment of osteoporosis. J Bone Miner Res 12(7):1100-7, 1997. PMID: 9200010.
326. Wong JH, Findlay JM, Suarez-Almazor ME. Hemodynamic instability after carotid endarterectomy: risk factors and associations with operative complications. Neurosurgery 41(1):35-41; discussion 41-3, 1997. PMID: 9218293.
327. Ramos-Remus C, Gamez-Nava JI, Gonzalez-Lopez L, Suarez-Almazor ME. Use of alternative medicine in a consecutive sample of patients with systemic lupus erythematosus. J Rheumatol 24(12):2490-1, 1997. PMID: 9415671.
328. Bruera E, Seifert L, Watanabe S, Babul N, Darke A, Harsanyi Z, Suarez-Almazor M. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage 11(3):147-53, 1996. PMID: 8851371.
329. Bruera E, Sloan P, Mount B, Scott J, Suarez-Almazor M. A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group. J Clin Oncol 14(5):1713-7, 1996. PMID: 8622092.
330. Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, Rosas E, Suarez-Almazor M, Cardona-Muñoz C, Ramos-Remus C. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 14(4):373-9, 1996. PMID: 8871835.
331. Lakey JR, Warnock GL, Rajotte RV, Suarez-Alamazor ME, Ao Z, Shapiro AM, Kneteman NM. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 61(7):1047-53, 1996. PMID: 8623183.
332. Avina-Zubieta JA, Johnson ES, Suarez-Almazor ME, Russell AS. Incidence of myopathy in patients treated with antimalarials. A report of three cases and a review of the literature. Br J Rheumatol 34(2):166-70, 1995. PMID: 7704464.
333. Maksymowych WP, Suarez-Almazor M, Chou CT, Russell AS. Polymorphism in the LMP2 gene influences susceptibility to extraspinal disease in HLA-B27 positive individuals with ankylosing spondylitis. Ann Rheum Dis 54(4):321-4, 1995. PMID: 7763114.
334. Bruera E, Franco JJ, Maltoni M, Watanabe S, Suarez-Almazor M. Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage 10(4):287-91, 1995. PMID: 7602179.
335. Suarez-Almazor ME, Soskolne CL, Saunders LD, Russell AS. Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness. J Rheumatol 22(5):836-43, 1995. PMID: 8587069.
336. Bruera E, Schoeller T, Wenk R, MacEachern T, Marcelino S, Hanson J, Suarez-Almazor M. A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage 10(5):348-55, 1995. PMID: 7673767.
337. de Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10(5):378-84, 1995. PMID: 7673770.
338. Maksymowych WP, Tao S, Luong M, Suarez-Almazor M, Nelson R, Pazderka F, Russell AS. Polymorphism in the LMP2 and LMP7 genes and adult rheumatoid arthritis: no relationship with disease susceptibility or outcome. Tissue Antigens 46(2):136-9, 1995. PMID: 7482508.
339. Bruera E, Watanabe S, Fainsinger RL, Spachynski K, Suarez-Almazor M, Inturrisi C. Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain 62(2):141-6, 1995. PMID: 8545138.
340. Davis P, Suarez-Almazor M. An assessment of the needs of family physicians for a rheumatology Continuing Medical Educational program: results of a pilot project. J Rheumatol 22(9):1762-5, 1995. PMID: 8523358.
341. Bruera E, de Stoutz ND, Fainsinger RL, Spachynski K, Suarez-Almazor M, Hanson J. Comparison of two different concentrations of hyaluronidase in patients receiving one-hour infusions of hypodermoclysis. J Pain Symptom Manage 10(7):505-9, 1995. PMID: 8537692.
342. Bruera E, Moyano J, Seifert L, Fainsinger RL, Hanson J, Suarez-Almazor M. The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage 10(8):599-603, 1995. PMID: 8594120.
343. Suarez-Almazor ME, Tao S, Moustarah F, Russell AS, Maksymowych W. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study. J Rheumatol 22(11):2027-33, 1995. PMID: 8596139.
344. Ramos-Remus C, Gomez-Vargas A, Guzman-Guzman JL, Jimenez-Gil F, Gamez-Nava JI, Gonzalez-Lopez L, Farrera-Gamboa H, Maksymowych WP, Suarez-Almazor ME. Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis. J Rheumatol 22(11):2120-5, 1995. PMID: 8596154.
345. Lakey JR, Warnock GL, Rajotte RV, Ao Z, Suarez-Almazor ME, Shapiro AM, Kneteman NM. Factors in cadaveric donors that affect recovery of human islets of Langerhans. Transplant Proc 27(6):3265, 1995. PMID: 8539945.
346. Anderson JJ, Weinblatt M, Furst D, Schmidt F, Williams HJ, Wilke W, Suarez-Almazor M, McKendry R, Bell M. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. Rheumatoid Arthritis Clinical Trial Archive Group. J Rheumatol 22(2):218-23, 1995. PMID: 7738941.
347. Reveille JD, Suarez Almazor ME, Russell AS, Go RC, Appleyard J, Barger BO, Acton RT, Koopman WJ, McDaniel DO. HLA in ankylosing spondylitis: is HLA-B27 the only MHC gene involved in disease pathogenesis?. Semin Arthritis Rheum 23(5):295-309, 1994. PMID: 7913556.
348. Maksymowych WP, Wessler A, Schmitt-Egenolf M, Suarez-Almazor M, Ritzel G, Von Borstel RC, Pazderka F, Russell AS. Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol 21(4):665-9, 1994. PMID: 8035391.
349. Ramos-Remus C, Suarez-Almazor M, Russell AS. Low tear production in patients with diabetes mellitus is not due to Sjögren's syndrome. Clin Exp Rheumatol 12(4):375-80, 1994. PMID: 7955600.
350. Suarez-Almazor ME, Soskolne CL, Saunders LD, Russell AS. Outcome in rheumatoid arthritis. A 1985 inception cohort study. J Rheumatol 21(8):1438-46, 1994. PMID: 7983643.
351. Ramos-Remus C, Suarez-Almazor M, Dorgan M, Gomez-Vargas A, Russell AS. Performance of online biomedical databases in rheumatology. J Rheumatol 21(10):1912-21, 1994. PMID: 7837159.
352. Bruera E, Suarez-Almazor M, Velasco A, Bertolino M, MacDonald SM, Hanson J. The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. J Pain Symptom Manage 9(8):515-9, 1994. PMID: 7531736.
353. Ramos-Remus C, Orozco-Barocio G, Suarez-Almazor M, Olguin-Redes J, Gomez-Vargas A, Avina-Zubieta A. Research in rheumatology: a six-month review of selected medical journals. Clin Exp Rheumatol 11(1):71-4, 1993. PMID: 8453803.
354. Suarez-Almazor ME, Flowerdew G, Saunders LD, Soskolne CL, Russell AS. The fluoridation of drinking water and hip fracture hospitalization rates in two Canadian communities. Am J Public Health 83(5):689-93, 1993. PMID: 8484450.
355. Suarez-Almazor ME, Soskolne CL, Fung K, Jhangri GS. Empirical assessment of the effect of different summary worklife exposure measures on the estimation of risk in case-referent studies of occupational cancer. Scand J Work Environ 18(4):233-41, 1992. PMID: 1411365.
356. Suarez-Almazor ME, Russell AS. Parenteral methotrexate or gold for rheumatoid arthritis: a follow up. Clin Exp Rheumatol 8(2):163-6, 1990. PMID: 2110877.
357. Suarez-Almazor ME, Russell AS. Sacroiliitis in psoriasis: relationship to peripheral arthritis and HLA-B27. J Rheumatol 17(6):804-8, 1990. PMID: 2388202.
358. Suarez-Almazor ME, Russell AS. The genetics of psoriasis. Haplotype sharing in siblings with the disease. Arch Dermatol 126(8):1040-2, 1990. PMID: 2383028.
359. Suárez-Almazor ME, Bruera E, Russell AS. Normal cardiovascular autonomic function in patients with systemic sclerosis (CREST variant). Ann Rheum Dis 47(8):672-4, 1988. PMID: 3415366.
360. Suarez-Almazor ME, Fitzgerald A, Grace M, Russell AS. A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis. J Rheumatol 15(5):753-6, 1988. PMID: 3139877.
361. Suarez-Almazor ME, Russell AS. Anterior atlantoaxial subluxation in patients with spondyloarthropathies: association with peripheral disease. J Rheumatol 15(6):973-5, 1988. PMID: 3418648.
362. Russell AS, Suárez-Almazor ME. Seronegative arthritis: psoriatic arthritis. Clin Exp Rheumatol 5 Suppl 1:S61-4, 1987. PMID: 3498601.
363. Suárez-Almazor ME, Russell AS. B27 homozygosity and ankylosing spondylitis. J Rheumatol 14(2):302-4, 1987. PMID: 3496453.
364. Suárez-Almazor ME, Russell AS, LeClercq S. Ankylosing spondylitis in families with two distinct B27 haplotypes: a selective association. Arthritis Rheum 29(12):1510-4, 1986. PMID: 3492209.
365. Suárez-Almazor ME, Catoggio LJ, Maldonado-Cocco JA, Cuttica R, García-Morteo O. Juvenile progressive systemic sclerosis: clinical and serologic findings. Arthritis Rheum 28(6):699-702, 1985. PMID: 3890869.
366. García-Morteo O, Suárez-Almazor ME, Maldonado-Cocco JA, Cuttica R, Abate S. Auranofin in juvenile rheumatoid arthritis. An open label, non-controlled study. Clin Rheumatol 3(2):223-7, 1984. PMID: 6432407.
367. García-Morteo O, Maldonado-Cocco JA, Suárez-Almazor ME, Garay E. Ankylosing spondylitis of juvenile onset: comparison with adult onset disease. Scand J Rheumatol 12(3):246-8, 1983. PMID: 6623013.

Invited Articles

1. Pundole X, Abdel-Wahab N, Suarez-Almazor ME. Arthritis risk with immune checkpoint inhibitor therapy for cancer. Curr Opin Rheumatol 31(3):293-299, 2019. PMID: 30870217.
2. Lopez-Olivo MA, Suarez-Almazor ME. Digital Patient Education and Decision Aids. Rheum Dis Clin North Am 45(2):245-256, 2019. e-Pub 2019. PMID: 30952396.
3. Suarez-Almazor M, Kim ST, Abdel-Wahab N, Diab A. Immune-related adverse events with use of vheckpoint inhibitors for immunotherapy of cancer. Arthritis and Rheumatology 69(4):687-699, 2017. PMID: 28085999.
4. Tayar J, Lopez-Olivo MA, Suarez-Almazor ME. Adalimumab; Eight years of experience in rheumatoid arthritis. International Journal of Clinical Rheumatology 8(2):164-184, 2013.
5. Suarez-Almazor ME.. Changing health behaviors with social marketing. Osteoporos Int 22 Suppl 3:461-3, 2011. PMID: 21847766.
6. Adler RA, Bates DW, Dell RM, Leboff MS, Majumdar SR, Saag KG, Solomon DH, Suarez-Almazor ME.. Systems-based approaches to osteoporosis and fracture care: policy and research recommendations from the workgroups. Osteoporos Int 22 Suppl 3:495-500, 2011. PMID: 21847772.
7. Waimann CA, Lu H, Suarez Almazor ME.. Rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease. Rheum Dis Clin North Am 37(4):527-49, 2011. PMID: 22075196.
8. Marengo MF, Suarez-Almazor ME, Lu H.. Neoplastic and paraneoplastic synovitis. Rheum Dis Clin North Am 37(4):551-72, 2011. PMID: 22075197.
9. Tayar JH, Suarez-Almazor ME. New understanding and approaches to treatment in rheumatoid arthritis. Br Med Bull 94(94):201-14, 2010. e-Pub 2010. PMID: 20200013.
10. de Achaval S, Suarez-Almazor ME. Improving treatment adherence in patients with rheumatologic disease. J Musculoskel Med 27(10):388-394, 2010.
11. Tayar J, Suarez-Almazor ME. Rheumatoid arthritis in women: Current approach and overview of recent guidelines. The Female Patient 9(34):16-20, 2009.
12. Suarez-Almazor ME. Is treatment with pulsed electromagnetic fields effective in knee osteoarthritis? [Commentary]. Nature Clinical Practice - Rheumatology 2:14-15, 2006.
13. Krishnan LL, Suarez-Almazor ME. Evidence-based rheumatology practice. Curr Opin Rheumatol 17(2):117-23, 2005. PMID: 15711221.
14. Jones CA, Beaupre LA, Johnston DW, Suarez-Almazor ME. Total joint arthroplasties: current concepts of patient outcomes after surgery. Rheum Dis Clin North Am 21(3):527-41, vi, 2005. PMID: 15911205.
15. Suarez-Almazor ME. Patient-physician communication. Curr Opin Rheumatol 16(2):91-5, 2004. PMID: 14770091.
16. Tugwell P, Welch V, Suarez-Almazor M, Shea B, Wells G. Efficacy and toxicity of old and new disease modifying antirheumatic drugs [Review]. Ann Rheum Dis 59(1):I32-I35, 2000.
17. Homik JE, Suarez-Almazor ME.. Clinical guidelines: a must for rheumatology? [Review]. Baillieres Clin Rheumatol 14:649-661, 2000.
18. Suarez-Almazor ME. Rheumatic diseases and the environment [Review]. NEJM 342:1144, 2000.
19. Suarez-Almazor ME, Kaul P. Health services research. Curr Opin Rheumatol 11(2):110-6, 1999. PMID: 10319213.
20. Russell AS, Suarez Almazor ME. Ankylosing spondylitis is not caused by Klebsiella. Rheum Dis Clin North Am 18(1):95-104, 1992. PMID: 1561412.
21. Suarez-Almazor ME, Russell AS. Clinical, laboratory and radiological features of the spondyloarthropathies [Review]. Medicine North Am 25:4655, 1988.

Other Articles

1. Suarez-Almazor M, Ortiz Z, Lopez-Olivo M, Pak C, Skidmore B. Kimmel B, Kallen M, Cox V, Roundtree A Infliximab and etenercept in rheumatoid arthritis: timing, dose escalation, and switching [Technology Report no 86]. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2007.
2. Suarez-Almazor M, Ortiz Z, Lopez-Olivo M, Moffett M, Pak C, Skidmore B. Kimmel B, Kallen M, Cox V Infliximab and etenercept in rheumatoid arthritis: systematic review of long-term clinical effectiveness, safety, and cost-effectiveness [Technology Report no 85]. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2007.
3. Suarez-Almazor M, Ortiz Z, Lopez-Olivo M, Moffett M, Pak C, Skidmore B. Kimmel B, Kallen M, Cox V Long-term clinical and cost-effectiveness of infliximab and etanercept for rheumatoid arthritis [Technology Overview no 29]. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2007.

Editorials

1. Buckley LM, Suarez-Almazor ME. Is Immune Check Point Inhibitor Treatment an Option for Patients with Rheumatic Diseases and Cancer?. Arthritis Rheumatol. PMID: 31379056.
2. Kim ST, Suarez-Almazor ME. Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists. Expert Rev Clin Immunol:1-3. PMID: 30589372.
3. Lopez-Olivo MA, Tayar JH, Suarez-Almazor ME. The updated guidelines on the use of rituximab in rheumatoid arthritis. Rheumatology (Oxford). PMID: 21546350.
4. Suarez-Almazor ME. High Burden of Rheumatic Disease in Mexico: A Comprehensive Community-based Epidemiological Study. J Rheumatol 38(1):8-9, 2011. PMID: 21196583.
5. de Achaval S, Suarez-Almazor M. Acetaminophen overdose: a little recognized public health threat. Pharmacoepidemiol Drug Saf 20(8):827-9, 2011. PMID: 21717529.
6. Suarez-Almazor ME. In Quest of the Holy Grail: Efficacy vs. Effectiveness in Rheumatoid Arthritis. J Rheumatol 29:209-211, 2002.
7. Suarez-Almazor ME. Unraveling Disparities in the Use of Elective Procedures. The Case of Total Joint Replacement. Med Care 40:447-450, 2002.
8. Suarez-Almazor ME, Homik J. Reducing Serologic testing for Rheumatic Diseases. Feasible goal or utopian dream?. J Rheumatol 26(12):2505-8, 1999. PMID: 10606352.
9. Findlay JM, Suarez-Almazor ME. Comments on 'Treatment for Intracranial Dural Arteriovenous Malformations: A Meta-analysis from the English Language Literature' by Lucas et al. Neurosurgery 40:1130-1131, 1997.

Abstracts

1. Lei X, Zhao H, Giordano SG, Vinod S, Suarez-Almazor ME. Systemic Lupus Erythematosus Is a Risk Factor for Mortality in Older Patients with Early-Stage Breast Cancer. ACR Convergence 2021, 2021.
2. Lei X, Blau B, Zhao H, Deswal A, Yazdany J, Giordano SH, Suarez-Almazor ME. Increased Risk of Major Adverse Cardiac Events in Patients with Systemic Lupus Erythematosus After Non-Cardiac Surgery. ACR Convergence 2021, 2021.
3. Karpes-Matusevich A, Lal LS, Chan W, Swint JM, Cantor SB, Suarez-Almazor ME, Lopez-Olivo MA. Discontinuation plays a role when evaluating the cost effectiveness of the second biological drug for patients with rheumatoid arthritis. Annual Meeting in Value in Health (ISPOR), 2020 Seoul, South Korea, 2020.
4. Lopez-Olivo MA, Volk R, Krause K, Suarez-Almazor ME. A review of smoking cessation strategies and lung cancer screening practices in patients with rheumatoid arthritis. Annual European Congress of Rheumatology (EULAR) 2020, E-Congress 79 (supplement 1):1422, 2020.
5. Manzano JG, Sharma S, Lopez-Olivo MA, Suarez-Almazor ME. Association of diabetes treatment with breast cancer outcomes: a systematic review and meta-analysis. Annual Meeting on Supportive Care in Cancer (MASCC), 2020 Seville,Spain, 2020.
6. Karpes-Matusevich A, Lal LS, Chan W, Swint JM, Cantor SB, Suarez-Almazor ME, Lopez-Olivo MA. Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy failure in patients with rheumatoid arthritis. Annual Meeting in Value in Health (ISPOR), 2020 Seoul, South Korea, 2020.
7. Pundole X, Lambotte O, Ramos-Casals M, et al. Immune checkpoint inhibitor therapy in patients with preexisting sarcoidosis. Annual European Congress of Rheumatology (EULAR) 2020, E-Congress 79:1221-1222, 2020.
8. Aldrich J, Pundole X, Tummala S, et al. Immune checkpoint-related myositis: a retrospective cohort study. Annual European Congress of Rheumatology (EULAR) 2020, E-Congress 79:395, 2020.
9. Aldrich J,Pundole X, Tummala S, Andersen C, Shoukier M, Abdel-Wahab N, Palaskas N, Deswal A, Suarez-Almazor ME. Incidence and outcomes of immune checkpoint inhibitor-related myositis. Annual European Congress of Rheumatology (EULAR) 2020, E-Congress 38(supplement 15):e15128-e15128, 2020.
10. Aldrich J,Pundole X, Tummala S, Andersen C, Shoukier M, Abdel-Wahab N, Palaskas N, Deswal A, Suarez-Almazor ME. Incidence and outcomes of immune checkpoint inhibitor-related myositis. American Society of Clinical Oncology (ASCO) Virtual Scientific Program 38:15_suppl, e15128-e15128, 2020.
11. Abdel-Wahab N, Diab A, Katayama H, Kim ST, Hanash S, Suarez-Almazor ME. Plasma Proteome Analysis in Patients with Immune Checkpoint Inhibitors Related Arthritis and Pneumonitis. Society for Immunotherapy of Cancer (SITC) Annual Meeting, 2020.
12. Sandigursky S, Safa H, Cytryn A, Efuni E, Pundole X, Buni M, Xia Y, Zhong H, Krogsgaard M, Pavlick A, Saberian C, Altan M, Suarez-Almazor ME, Weber JS, Diab A,Abdel-Wahab N. Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases. Society for Immunotherapy of Cancer (SITC) Annual Meeting, 2020.
13. Saberian C, Fa’ak F, Tayar J, Buni M, Kim ST, Lu L, Suarez-Almazor ME, Gruschkus SK, Daher M, Ludford K, Johnson D, Abdel-Wahab N, Diab A. Interleukin-6 Receptor Blockade for Management of Immune Checkpoint Inhibitor Related Adverse Events in Patients with Melanoma. Society for Immunotherapy of Cancer (SITC) Annual Meeting, 2020.
14. Ramos-Casals M, Maria A, Suárez-Almazor M, Lambotte O, Fisher B, Hernandez-Molina G, Guilpain P, Pundole X, Retamozo S, Flores-Chávez A, Baldini C, Bingham C, Brito-Zerón P, Gottenberg J, Kostine M, Radstake T, Schaeverbeke T, Schulze-Koops H, Calabrese L, Khamashta M, Mariette X. Sicca/Sjögren Syndrome Triggered by PD-1/PD-L1 Checkpoint Inhibitors: Data from the International ImmunoCancer Registry (ICIR). Arthritis Rheumatol 71 (suppl 10), 2019.
15. Lopez-Olivo M, Abdel-Wahab N, Suárez-Almazor M. A Systematic Review and Meta-analysis of Observational Studies Reporting on the Use of Checkpoint Inhibitors in Patients with Cancer and Pre-existing Autoimmune Disease. Arthritis Rheumatol 71 (suppl 10), 2019.
16. Karpes A, Duan Z, Zhao H, Lal L, Chan W, Suárez-Almazor M, Giordano S, Swint J, Lopez-Olivo M. Treatment Sequences, Effectiveness, and Costs of Tumor Necrosis Factor Inhibitor Cycling Compared with Swapping to a Novel Disease-modifying Anti-rheumatic Drug in Rheumatoid Arthritis Patients. Arthritis Rheumatol 71 (suppl 10), 2019.
17. Kim S, Tayar J, Suárez-Almazor M, Lu H, Zhao Y, Liu Z, Rodriguez E, Neelapu S, Wang J, Shah A, Tannir N, Gibbons D, Garcia-Manero G, Tawbi H, Hwu P, Futreal A, Diab A, Nurieva R. Enrichment of IL-17-producing CD4+ T Cells in Synovial Fluid from Patients with Arthritis After anti-CTLA-4 and anti-PD-1 Combination Therapy. Arthritis Rheumatol 71 (suppl 10), 2019.
18. des Bordes J, Foreman J, Lopez-Olivo M, Peterson S, Westrich-Robertson T, Hofstetter C, Lyddiatt A, Leong A, Suárez-Almazor M. Physical Challenges in RA: A Qualitative Study of an Online Patient Support Group. Arthritis Rheumatol 71 (suppl 10), 2019.
19. Lopez-Olivo MA, Suarez-Almazor ME. Prescriber attitudes and beliefs about triple therapy for patients with rheumatoid arthritis: Knowledge exchange in internet forums and social media. JCR 2019 Annual Scientific Meeting. 2019 Kyoto, Japan, 2019.
20. Ramos-Casals M, Lambotte O, Kostine M, , et al. Immune-Related Adverse Events Induced by Cancer Immunotherapies. Big Data Analysis of 13,051 Cases (Immunocancer International Registry). Annual European Congress of Rheumatology (EULAR) 2019, Madrid, Spain, 2019.
21. Ramos-Casals, Manuel; Lambotte, Oliver; Kostine, Marie; et al.. Immune checkpoint inhibitors in patients with cancer and rheumatalogic diseases: A systematic review of the literature. Annual European Congress of Rheumatology (EULAR) 2019 Madrid, Spain, 2019.
22. Abdel-Wahab N, Safa H, Abudayyeh A, et al. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: An institutional experience and a systematic review of the literature. Journal for ImmunoTherapy of Cancer, 2019.
23. Tarp Simon, Jorgensen Tanja, Furst C, Daniel E, et al. Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trials. Seminars is Arthtitis and R 48(6):958-966, 2019.
24. Singh, Jasvinder A.; Fraenkel, Liana; Green, Candace; et al.. Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial. PLOS Medicine 16(5), 2019.
25. Abdel-Wahab N, Safa H, Lopez-Olivo MA, et al. Immunecheckpoint inhibitors in patients with cancer and rheumatologic diseases: A systematic review of the literature. European League Against Rheumatism (EULAR) Annual Meeting, Madrid, Spain 78 (Suppl 2)(624), 2019.
26. Singh J, Fraenkel L, Green C, Alarcon GS, Barton J, Saag K, Hanrahan L, Raymond S, Kimberly R, Leong A, Reyes E, Street R, Suarez-Almazor M, Eakin G, Marrow L, Morgan C, Caro B, Sloan J, Jandali B, Garcia S, Grossman J, Winthrop K, Trupin L, Dall'era M, Meara A, Rizvi T, Chatham W, Yazdany J. An individualized decision-aid for diverse women with lupus nephritis (idea- won): a randomized controlled trail. The European League Against Rheumatism Congress (EULAR), Madrid, Spain 78 (suppl 2):A621, 2019.
27. Abdel-Wahab N, Safa H, Lopez-Olivo MA, Diab A, Suarez-Almazor M. Immune checkpoint inhibitors in patients with cancer and rheumatologic disease: a systematic review of the literature. The European League Against Rheumatism Congress (EULAR), Madrid, Spain 78 (suppl 2):A624, 2019.
28. Abdel-Wahab N, Yu RK, Diab A, Dadu R, Shannon V, Futreal A, Criswell L, Shete S, Suarez-Almazor ME. Genetic determinants of adverse events in cancer patients receiving immune checkpoint inhibitors. J Clin Oncol (Suppl) 37(15):2586-2586, 2019.
29. 23. Saberian C, Abdel-Wahab N, Suarez-Almazor ME, Al-Atrash G, Abudayyeh A, Diab A. Use of checkpoint inhibitors (CPI) in allogeneic stem cell transplant recipients: An institutional experience and a systemic review of the literature. Ann Oncol (Suppl), 2019.
30. Pundole X, Zamora N, Siddhanamatha H, Tayar J, Leung CH, Lin H, Suarez-Almazor ME. Time dependent effect of biologic therapy on overall survival in patients with rheumatoid arthritis and cancer. Arthritis Rheum 70 (Suppl 10), 2018.
31. Torres HA, Lok AS, Suarez-Almazor ME, Warneke CL, Miller E, Kaseb A, Sturgis E, Angelidakis G, Ahmed S, Ferrajoli A, Samaniego F, Hawk E, Hwang JP. Hepatitis C Virus risk tool for patients with cancer. The American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, Illinois, 2018.
32. Pundole X, Sarangdhar M, Suarez-Almazor ME. Cardiovascular toxicity of immune checkpoint inhibitors: Analyzing emerging trends within the FAERS data. Support Care Cancer 26 (Suppl 2):S39–S364, 2018.
33. Abdel-Wahab N, Shah M, Suarez-Almazor ME. Allo-Immunity and graft rejection after checkpoint inhibitor therapy (CPI) in solid organ transplant (SOT) recipients. J Clin Oncol 36, 2018.
34. Abdel-Wahab N, Abudayyeh A, Lei X, Alatrash G, Zhao H, Giordano SH, Safa H, Johnson DH, Trinh V, Abdelrahim M, Gaber A, Suarez-Almazor ME. Checkpoint inhibitor therapy in solid organ and allogeneic stem cell transplantation: Data mining of the truven health marketscan research database. The Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting, Washington, DC, 2018.
35. Safa H, Abdel-Wahab N, Trinh VA, Johnson DH, Rodgers TE, Suarez-Almazor ME, Diab A. Use of immune checkpoint inhibitors (CPI) in patients with cancer and concominant myasthenia gravis (MG). Ann Oncol 29 (Suppl 7), 2018.
36. Zogala R, Criner K, Lopez-Olivo MA, Zamora N, Rai D, Pratt G, des Bordes JKA, Christensen R, Suarez-Almazor M. Patient-reported outcome measures used in rheumatoid arthritis cohorts and registries around the world: an environmental scan from the outcome measures in rheumatology critical outcomes in longitudinal observational studies working group. Arthritis Rheumatol 70 (Suppl 10), 2018.
37. Lopez-Olivo MA, Tayar J, Zamora N, Pratt G, Suarez-Almazor M. Malignancies and serious infections in randomized controlled trials of Janus Kinase inhibitors in patients with rheumatoid arthritis: A systematic review and meta-analysis. Arthritis Rheumatol 70 (Suppl 10), 2018.
38. Pundole X, Lopez-Olivo MA, Suarez-Almazor M; et al.. Anti-sclerostin antibodies for the treatment of osteoporosis: A systematic review and meta-analysis. Annual Meeting of the American Society for Bone and Mineral Research, Montreal, Canada 33 (Suppl 1):411-412, 2018.
39. Hwang, Jessica P.; Huang, Danmeng; Vierling, John M.; et al.. Cost-Effectiveness analysis of hepatitis B virus screening and management in patients with hematologic or solid malignancies anticipating immunosuppressive cancer therapy. Annual Meeting of the AmericanAssociation for the Study of Liver Diseases (AASLD) / Liver Meeting, San Francisco, CA 68 (Suppl 1):570A-570A, 2018.
40. Lopez-Olivo MA, Matusevich A, Cantor SB, et al. The comparative effectiveness of cycling tumor necrosis factor inhibitor (TNFi) versus swapping to a nontnfi on patient-reported functional ability of patients with rheumatoid arthritis. Arthritis Rheu 70 (Suppl 9), 2018.
41. Lopez-Olivo MA, Foreman J, Lin H, et al.. Effects of social networking on chronic disease management in rheumatoid arthritis. Arthritis Rheum 70 (Suppl 9), 2018.
42. Lopez-Olivo MA, des Bordes JKA, Pratt G, et al. Prescriber attitudes and beliefs about triple therapy for patients with rheumatoid arthritis: Knowledge exchange in internet forums and social media. Arthritis Rheum 70(9), 2018.
43. Lopez-Olivo MA, Tayar J, Zamora N, et al.. Malignancies and serious infections in randomized controlled trials of Janus Kinase inhibitors in patients with rheumatoid arthritis: A systematic review and meta-analysis. Arthritis Rheum 70 (Suppl 9), 2018.
44. Pundole X, Zamora N, Siddhanamatha H, et al.. Time Dependent Effect of Biologic Therapy on Overall Survival in Patients with Rheumatoid Arthritis and Cancer. Arthritis Rheum 70 (Suppl 9), 2018.
45. Toupin AK, Barton J, Fraenkel L, et al.. Development a Core Domain Set to Assess Shared Decision Making Interventions in Rheumatology: An OMERACT White Paper to Facilitate Endorsement. Arthritis Rheum 70(9), 2018.
46. Zogala R, Criner K, Lopez-Olivo MA, et al.. Patient-reported outcome measures used in rheumatoid arthritis cohorts and registries around the world: an environmental scan from the outcome measures in rheumatology critical outcomes in longitudinal observational studies working group. Arthritis Rheum 70 (Suppl 9), 2018.
47. Lopez-Olivo MA, Tayar JH, Zamora NV, et al.. Malignancies and serious infections in randomized controlled trials of Janus Kinase inhibitors in patients with Rheumatoid Arthritis: A systematic review and meta-analysis. Congress of the European League Against Rheumatism (EULAR), Amsterdam, Netherlands 77 (Suppl 2):66, 2018.
48. Pundole X, Sarangdhar M, Suarez-Almazor ME. Rheumatic and musculoskeletal adverse events assoicated with immune checkpoint inhibitors: Data mining of the Food and Drug Administraton Adverse Event Reporting System. Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands 77 (Suppl 2):147-148, 2018.
49. Lopez-Olivo MA, des Bordes KA, Pratt G, et. al. Prescribers attitudes and beliefs about triple therapy for patients with Rheumatoid Arthritis: Knowledge excanchge in internet forums and social media. Arthritis Rheum 70(9), 2018.
50. Lopez-Olivo MA, Matusevich A, Cantor SB, et.al.. The comparative effectiveness of cycling tumournecrosis factor inhibitor (TNFI) versus swapping to a NonTFNI on patient-reported functional ability of patients with rheumatoid arthritis. Congress of the European League Against Rheumatism (EULAR), Amsterdam, Netherlands 77 (Suppl 2):196, 2018. e-Pub 2018.
51. Hwang J, Torres HA, Lok A, et al. Hepatitis C virus infection risk tool for patients with cancer. J Clin Oncol 36(15), 2018.
52. Pen RA, Herrera RA, Lei X, Chavez-MacGregor M, et al. Overall survival in female medicare beneficiaries with early stage breast cancer receiving bisphosphonates or denosumab. Annual National Meeting of the Society of General Internal Medicine, San Francisco, California 36(10):959, 2018.
53. Alshawa A, Fujii T, Sbeih A, et al. Hepatotoxicity in advanced cancer patients receiving immune-based cancer treatment. ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco, California 36(5), 2018.
54. Hassan NA, Abudayyeh A, Shah M. The outcome of checkpoint inhibitor therapy in patients with cancer and solid organ transplant: A systematic review of the literature. ASO-SITC Clinical Immuno-Oncology Symposium, San Francisco, California 36, 2018.
55. Safa H, Abdel-Wahab N, Trinh VA, et al. Use of immune checkpoint inhibitors (CPI) in patients with cancer and contaminant myasthenia gravis (MG). 43rd ESMO Congress (ESMO), Munich, Germany 29 (Suppl 8), 2018.
56. Hwang JP, Lok AS, Fisch M, et al. The comparative effectiveness of cycling tumor necrosis factor inhibitor (TNFi) versus swapping to a nontnfi on patient-reported functional ability of patients with rheumatoid arthritis. Annual National Meeting of the Society of General Internal Medicine (SGIM), Washington, DC 36(10), 2018.
57. Pundole X, Sarangdhar M, Suarez-Almazor M. Rheumatic and musculoskeletal adverse events associated with immune checkpoint inhibitors: Data mining of the US Food and Drug Administration Adverse Event Reporting System. Annals of the Rheumatic Diseases 77:147-148, 2018.
58. Pundole X, Shah M, Abdel-Wahab N, Suarez-Almazor M. Immune checkpoint inhibitors and inflammatory myopathies: Data from the US Food and Drug Administration Adverse Event Reporting System. Arthritis Rheumatol 69 (Suppl 10), 2017.
59. Shah M, Tayar J, Abdel-Wahab N, Suarez-Almazor M. Myositis as a complication of checkpoint blockade at a comprehensive cancer center. Arthritis Rheumatol 69 (Suppl 10), 2017.
60. Zamora NV, Lopez-Olivo MA, Tayar J, Christensen R, Suarez-Almzaor M. Comparative effectiveness of tofacitinib versus baricitinib in rheumatoid arthritis using a systematic review and network meta-analysis of randomized trials. Arthritis Rheum 69 (Suppl 10), 2017.
61. Abdel-Wahab N, Tayar JH, Diab A, Kim ST, Lu H, Suarez-Almazor ME. Inflammatory arthritis induced by the use of checkpoint inhibitors for immunotherapy of cancer. Journal for ImmunoTherapy of Cancer Suppl 5(2), 2017.
62. Abdel-Wahab N, Shah M, Suarez-Almazor ME. A systematic review of the management of patients with preexisting rheumatologic diseases receiving checkpoint inhibitors for cancer. Arthritis Rheum Suppl 69(10), 2017.
63. des Bordes JKA, Foreman J, Peterson SK, Lopez-Olivo MA, Westrich-Robertson T, Hofstetter C, Lyddiatt A, Leong AL, Suarez-Almazor ME. Experiences and perceptions of patients with rheumatoid arthritis participating in an online support group: the use of social media [abstract 66083]. Arthritis Rheumatol, 2017.
64. Lopez-Olivo MA, Matusevich A, Suarez-Almazor ME. Cycling versus swapping in patients with rheumatoid arthritis with an inadequate response to at least one tumor necrosis factor alpha inhibitor: A systematic review and meta-analysis of observational studies. The European League Against Rheumatism Congress (EULAR), Madrid, Spain 76 (suppl 2):851, 2017.
65. Suarez-Almazor ME, Cabanillas Salazar GM, Zhao H, Kim J, Elting L. Dual Energy X-ray Absorptiometry Testing in Elderly Men with Prostate Cancer Initiating Androgen Deprivation Therapy Reduces Subsequent Fracture Risk. The European League Against Rheumatism Congress (EULAR), Madrid, Spain 76 (suppl 2):692, 2017.
66. Ursani MA, Suarez-Almazor M, Yang M, Lu HF, Zhao H, Elting L. Dual energy x-ray absorptiometry testing in women with breast cancer initiating therapy with aromatase inhibitors reduces subsequent fracture risk. The European League Against Rheumatism Congress (EULAR), Madrid, Spain 72 (suppl 2):692, 2017.
67. Klokker L, Woodworth T, Furst DE, Tugwell P, Devoe D, Terwee CB, Suarez-Almazor ME, Strand V, Leong AL, Goel N, Boers M, Brooks PM, Simon LS, Christensen R, on behalf of OMERACT working group. Outcome measurement instruments for safety in rheumatology: a scoping review of available instruments to inform the omeract safety working group. The European League Against Rheumatism Congress (EULAR), Madrid, Spain 76 (suppl 2):463, 2017.
68. Zamora NV, Siddhanamatha H, Barbo A, Tayar J, Lin H, Suarez-Almazor M. Utilization of biologic therapy in patients with rheumatoid arthritis and cancer. American College of Rheumatology Conference (ACR), Washington, DC, 2016.
69. Ninna K, Senftleber NK, Nielsen SM, Jens RA, Bliddal H, Tarp S, Lauritzen L, Daniel EF, Suarez-Almazor ME, Lyddiatt A, Christensen R. Fish oil supplements for arthritis pain: A systematic review and meta-analysis of randomized trials. 38th ESPEN Congress, Copenhagen, Denmark, 2016.
70. Zamora NV, Tayar J, Lopez-Olivo MA., Christensen R, Suarez-Almazor ME. Baricitinib for rheumatoid arthritis: A systematic review and meta-analysis. The European League Against Rheumatism (EULAR) Annual Confernce, London, United Kingdom, 2016.
71. Fujii T, Colen R, Bilen M, Hess K, Hajjar J, Suarez-Almazor M. Incidence of Immune-related adverse events in patients who received immunotherapy and radiographic analysis to predict pneumonitis. 28th European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR) Symposium, Munich, Germany, 2016.
72. Tarp S, Furst DE, Dossing A, Østergaard M, Lorenzen T, Hansen MS, Singh JA, Choy EH, Boers M, Suarez-Almazor ME, Kristensen LE, Bliddal H, Christensen R. Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and network meta-analysis of randomised trials. The European League Against Rheumatism (EULAR) Annual Confernce, London, United Kingdom, 2016.
73. Lo GH, Driban JB, McAlindon TE, Eaton C, Kent CK, Kriska A, Souza R, Petersen NJ, Storti K, Hochberg M, Jackson RD, Nevitt MC, Suarez-Almazor M. Swimming may associate with less osteoarthritis: Data from the osteoarthritis initiative. American College of Rheumatology (ACR) Conference (ACR), Washington, DC, 2016.
74. Garcia SR, Lopez-Olivo MA, Suarez-Almazor M. Treatments for early rheumatoid arthritis (RA): A systematic review of randomized controlled trials. American College of Rheumatology (ACR) Conference, Washington, DC, 2016.
75. Lopez-Olivo MA, Matusevich A, Suarez-Almazor M. Therapy in patients with rheumatoid arthritis (RA) with inadequate response to tumor necrosis factor alpha inhibitors (TNFi): A systematic review and meta-analysis of randomized controlled trials (RCTs). American College of Rheumatology Conference (ACR), Washington, DC, 2016.
76. Abdel-Wahab N, Lopez-Olivo MA, Suarez-Almazor M. Antiphospholipid antibodies and related clinical events following infection in children: A systematic review of case reports. American College of Rheumatology (ACR) Conference, Washington, DC, 2016.
77. Barbo A, Suarez-Almazor M, Lopez-Olivo MA. Impact of decision-making role preferences in the efficacy of a multimedia patient education tool for patients with common rheumatologic conditions. American College of Rheumatology Conference, Washington, DC, 2016.
78. Zamora NV, Lopez-Olivo MA, Christensen R, Goel N, Kristensen LE, Strand V, Jeffrey RC, Shea B, Suarez-Almazor M. Environmental scan of rheumatoid arthritis patient registries around the world: An Omeract initiative. American College of Rheumatology (ACR) Conference, Washington, DC, 2016.
79. Abdel-Wahab N, Shah M, Suarez-Almazor ME. Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune diseases: A systematic review of case reports. American College of Rheumatology (ACR) Conference, Washington, DC, 2016.
80. Zamora NV, Tayar J, Lopez-Olivo MA, Christensen R, Suarez-Almazor M. Baricitinib for rheumatoid arthritis: A systematic review and meta-analysis. American College of Rheumatology (ACR) Conference, Washington, DC, 2016.
81. Zamora NV, Lopez-Olivo MA, Christensen R, Goel N, Kristensen LE, Strand V, Curtis JR, Shea B, Suarez-Almazor M. Environmental scan of rheumatoid arthritis patient registries around the world: An Omeract initiative. The Outcomes Measures in Rheumatology (OMERACT) Conference, Whistler, BC, Canada, 2016.
82. Zamora NV, Tayar J, Lopez-Olivo MA, Christensen R, Suarez-Almazor ME. Baricitinib for rheumatoid arthritis: A systematic review and meta-analysis. The European League Against Rheumatism Congress (EULAR), London, United Kingdom 75 (Suppl 2):731, 2016.
83. Zamora NV, Tayar J, Lopez-Olivo MA, Christensen R, Suarez-Almazor ME. Baricitinib for rheumatoid arthritis: A systematic review and meta-analysis. American College of Rheumatology (ACR) Annual Scientific Meeting, Washington,DC 68 (Suppl 10), 2016.
84. Zamora NV, Siddhanamatha H, Barbo A, Tayar J, Lin H, Suarez-Almazor M. Utilization of biologic therapy in patients with rheumatoid arthritis and cancer. American College of Rheumatology (ACR) Annual Scientific Meeting , Washington, DC 68 (Suppl 10), 2016.
85. Abdel-Wahab N, Shah M, Suarez-Almazor ME. Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune diseases: A systematic review of case reports. Arthritis Rheum (Suppl) 68(10), 2016.
86. Abdel-Wahab N, Lopez-Olivo MA, Suarez-Almazor M. Antiphospholipid antibodies and related clinical events following infection in children: A systematic review of case reports. Arthritis Rheum Suppl 68(10):S1060, 2016.
87. Manzano J, Yang M, Zhao H, Elting L, Suarez-Almazor M. Survival outcomes of patients with gastrointestinal cancer who experienced unplanned readmissions. Society of Hospital Medicine Annual Meeting, San Diego, California, 2016.
88. Valerio-Morales, I, Lopez-Olivo, MA, Pan, X, Suarez-Almazor, ME. A phosphodiesterase 4 inhibitor for psoriatic arthritis: Systematic review and meta-analysis. American College of Rheumatology (ACR) Conference, San Francisco, CA 67 (suppl 10), 2015.
89. Suarez-Almazor, ME, Lopez-Olivo MA, Abdel-Wahab N. Risk of developing antiphospholopid syndrome following human immunodeficiency virus infection: A systematic and meta-analysis of observational studies. Third International Congress on Controversies in Rheumatology & Autoimmunity (CORA), 2015.
90. Suarez-Almazor, ME;. Effects of social networking on chronic disease management in arthritis. Rheumatology Research Foundation: 2015 Investigators' Meeting, 2015.
91. Lopez-Olivo, MA, Heung, E, Ojeda-Prias, A, Leong, A, Willcockson, I, Suarez-Almazor,ME. Quality assessment of websites providing educational content about rheumatoid arthritis. American College of Rheumatology (ACR) Conference (ACR), San Francisco, CA, 2015.
92. Kakpovbia-Eshareturi, V, des Bordes, J, Lopez-Olivo, MA, Christensen, R, Suarez-Almazor, ME. The treatment of undifferentiated arthritis: A systematic review and meta-analysis of randomized clinical trials. American College of Rheumatology (ACR) Conference (ACR), San Francisco, CA, 2015.
93. Pundole, X, Lopez-Olivo, MA, Cheema, HI, Sanchez-Pettito, G, Suarez-Almazor, ME, Lu, H. Prevention and treatment of bone loss following hematopoietic stem cell transplantation: A systematic review and meta-analysis. American College of Rheumatology (ACR) Conference, San Francisco, CA, 2015.
94. Lopez-Olivo, MA, Barbo, A, Rizvi, T, Volk, R, Lin, H, Saurez-Almazor, ME. A randomized controlled trial to evaluate a multimedia patient education tool in patients with knee osteoarthritis. Six-month results. American College of Rheumatology (ACR) Conference, San Francisco, CA , 2015.
95. Lopez-Olivo, MA, Barbo, A, Rizvi, T, Volk, R, Lin, H, Suarez-Almazor, ME. Improving outcomes with a multimedia patient education tool in patients with osteoporosis after 6 months. A randomized controlled trial. 2015 American College of Rheumatology (ACR) Conference, San Francisco, CA, 2015.
96. Lopez-Olivo, MA, Barbo, A, Rizvi, T, Volk, R, Lin, H, Suarez-Almazor, ME. Six-month effects of a multimedia patient education tool in patients with rheumatoid arthritis. A randomized controlled trial. American College of Rheumatology (ACR) Conference (ACR), San Francisco, CA, 2015.
97. Cardenas-Turanzas, M, Gonzalez, E, Shethia, M, Lopez-Olivo, MA, Nayak, P, Suarez-Almazor, ME. Assessing information needs for chronic disease management in rheumatoid arthritis. American College of Rheumatology (ACR) Conference, San Francisco, CA 67 (suppl 10), 2015.
98. Abdel-Wahab, N, Suarez-Almazor, ME. Immune related adverse events associated with immune checkpoint inhibitors in cancer patients: A systematic review of case reports. American College of Rheumatology Conference (ACR), San Francisco, CA 67(10):1768-1770, 2015.
99. des Bordes JK, Abdel-Wahab N, Suarez-Almazor ME, Lopez-Olivo MA. Assessing information needs on bone health in cancer survivors. J Cancer Surviv, 2015.
100. Basra G, Cardenas-Turanzas M, Andrabi T, French KE, Bellard B, Murphy WA Jr., Lopez-Olivo MA, Suarez-Almazor ME. Fiber Optic Intubation in Patients with Rheumatoid Arthritis Who Had a Surgical Procedure. American College of Rheumatology (ACR) Conference, San Francisco, CA 67 (suppl 10), 2015.
101. Abdel-Wahab N. Lopez-Olivo MA, Patarroyo-Pinto P, Suarez-Almazor ME. Antiphospholipid syndrome following infection: A systematic review. American College of Rheumatology (ACR) Conference, Boston, MA, 2014.
102. Lopez-Olivo MA, Ingleshwar A. Volk R, Barbo A, Jibaja-Weiss M, Suarez-Almazor ME. Development of multimedia patient education tools (MM-PtET) for osteoarthritis (OA), osteoporosis (OP) and rheumatoid arthritis patients (RA). American College of Rheumatology (ACR) Conference, Boston, MA, 2014.
103. Lo, Grace H., Driban, Jeffrey B., Kriska, Andrea, Shorti, Kristi, McAlindon, Timothy E., Souza, Richard, Eaton, Charles B., Petersen, Nancy J., Suarez-Almazor, ME. Habitual running any time in life is not detrimental and may be protective of symptomatic knee osteoarthritis: Data from the osteoarthritis initiative. American College of Rheumatology (ACR), Boston, MA, 2014.
104. Luo, R., Elting, L., Suarez-Almazor, ME. Impact of rheumatoid arthritis on the mortality of patients who develop cancer: A population-based study. American College of Rheumatology (ACR) Conference, Boston, MA, 2014.
105. Siricilla, M., Luo, R., Elting, L., Suarez-Almazor, ME. Low rates of bone mineral density testing in medicare beneficiaries with breast cancer starting aromatase inhibitor therapy. 2014 American College of Rheumatology (ACR) Conference, Boston,MA, 2014.
106. Zahr, ZA, Luo, R., Elting, L., Suarez-Almazor, ME. Mortality risk in patients with rheumatoid arthritis who develop Non–Hodgkin′s Lymphoma. American College of Rheumatology (ACR) Conference (ACR), Boston, MA, 2014.
107. Lopez-Olivo MA, Ingleshwar A. Volk R, Barbo A, Jibaja-Weiss M, Lin H, Suarez-Almazor ME. Multimedia patient education tool for patients with osteoporosis. American College of Rheumatology Conference (ACR), Boston, MA, 2014.
108. Lopez-Olivo MA, Ingleshwar A. Volk R, Barbo A, Jibaja-Weiss M, Lin H, Suarez-Almazor ME. Multimedia patient education tool for patients with rheumatoid arthritis. American College of Rheumatology Conference (ACR), Boston, MA, 2014.
109. Peddi M, Lopez-Olivo MA, Peddi P, Espinosa Cuervo G, Suarez-Almazor ME. Physical therapy for systemic sclerosis: Systematic review and meta-analysis. 2014 American College of Rheumatology (ACR) Conference, Boston, MA, 2014.
110. Lopez-Olivo MA, Abdel-Wahab N, Dodeja A, Pratt G, Suarez-Almazor ME. Quality appraisal of educational websites on osteoporosis and bone health. American College of Rheumatology (ACR) Conference, Boston, MA, 2014.
111. Pan X, Lopez-Olivo MA, Nayak P, Suarez-Almazor ME. Quality assessment of controlled trials evaluating Chinese herbal medicine in Patients with Rheumatoid Arthritis: A systematic review. American College of Rheumatology (ACR) Conference, Boston, MA, 2014.
112. Abdel-Wahab N. Lopez-Olivo MA, Talathi S, Suarez-Almazor ME. Risk of developing antiphospholipid syndrome following infection: A systematic review and meta-analysis of observational studies. American College of Rheumatology (ACR) Conference, Boston, MA, 2014.
113. Manzano J, Luo R, Elting L, George M, Suarez-Almazor ME. Unplanned 30-day readmissions among patients with gastrointestinal cancer. Supportive Care in Cancer 2014 (Suppl 1), 2014.
114. Abdel-Wahab N, Lopez-Olivo MA, Siddhanamatha HR, Suarez-Almazor ME. The relationship between infection and Anti-Phospholipid Syndrome: A systemic review of case reports. The European League Against Rheumatism Congress (EULAR), Paris, France 73 Supl 2:181-182, 2014.
115. Lopez-Olivo MA, Abdel-Wahab N, Dodeja A, Pratt G, Suarez-Almazor ME. Quality appraisal of educational websites on osteoporosis and bone health. American College of Rheumatology (ACR) Annual Scientific Meeting, Boston, MA, 2014 66 (Suppl 10):S884, 2014.
116. Lo GH, McAlindon TE, Katz JN, Driban JB, Price LL, Eaton CB, Petersen NJ, Ballantyne CM, Suarez-Almazor ME. Elevated systemic blood pressure is associated with increased prevalent knee osteoarthritis and knee pain: Data from the osteoarthritis initiative. American College of Rheumatology Conference (ACR), San Diego, CA, 2013.
117. Ingleshwar, Aparna, Lopez-Olivo, Maria A., Landon, Glenn C., Siff, Sherwin J., Barbo, Andrea, Suarez-Almazor ME. Psychosocial determinants of total knee arthroplasty outcomes 2 years after surgery. American College of Rheumatology Conference (ACR), San Diego, CA, 2013.
118. Ingleshwar, Aparna, Barbo, Andrea, Landon, Glenn C., Siff, Sherwin J, De Achaval, Sofia, Suarez-Almazor,ME. Ethnic variations at time of surgery and during follow-up in patients undergoing total knee arthroplasty. American College of Rheumatology Conference (ACR), San Diego, CA, 2013.
119. Lopez-Olivo, Maria A, Martínez-López,Juan A., Tayar, Jean H., Bavineni, Mahesh, Suarez-Almazor ME. Adverse events with the use of radiotherapy in patients with vonnective tissue diseases and cancer: A systematic review and meta-analysis. American College of Rheumatology (ACR) Conference, San Diego, CA, 2013.
120. Lopez-Olivo, Maria A., Volk, Robert, Jibaja-Weiss, Suarez-Almazor ME. Preferred strategies for delivering treatment Information to people with rheumatoid arthritis, osteoarthritis and osteoporosis. American College of Rheumatology Conference (ACR), San Diego, CA, 2013.
121. Lopez-Olivo, Suarez-Almazor ME, Bavineni, Mahesh. Tofacitinib for rheumatoid arthritis: A systematic review and meta-analysis. American College of Rheumatology (ACR) Conference (ACR), San Diego, CA, 2013.
122. Manzano J, Luo R, Elting L, Suarez-Almazor ME. 30-day readmission among gastrointestinal cancer patients in Texas. American College of Clinical Oncology (ASCO), San Diego, CA, 2013.
123. Lopez-Olivo MA, Martinez-Lopez JA, Tayar J, Bavineni M, Fulton S, Suarez-Almazor ME. A meta-analysis on the use of radiotherapy in patients with connective tissue diseases and cancer. Annuals of Rheumatic Diseases 73 (Suppl 3)(565), 2013.
124. Lopez-Olivo MA, Martinez-Lopez JA, Tayar J, Bavineni M, Fulton S, Suarez-Almazor ME. Adverse events with the use of radiotherapy in patients with connective tissue diseases and cancer: A systematic review and meta-analysis. Arthritis Rheum 72 (suppl 3), 2013.
125. Lopez-Olivo MA, Martinez-Lopez JA, Tayar J, Bavineni M, Fulton S, Suarez-Almazor ME. A meta-analysis on the use of radiotherapy in patients with connective tissue diseases and cancer. Division of Internal Medicine Research Retreat, 2013.
126. Lopez-Olivo MA, Tayar J, Fulton S, Suarez-Almazor ME. Tofacitinib for rheumatoid arthritis: A systematic review and meta-analysis. Arthritis Rheum, 2013.
127. Christensen R, Tarp S, Furst DE, Østergaard M, Lorenzen T, Hansen MS, Singh JA, Choy EH, Boers M, Suarez-Almazor ME, Ejbjerg B, Kristensen LE, Bliddal H. Defining the optimal biological monotherapy in rheumatoid arthritis (RA): Network meta-analysis of randomized trials. The European League Against Rheumatism Congress (EULAR), Madrid, Spain 72 (suppl 3), 2013.
128. Suarez-Almazor M, Landon G, Luo R, Singh J. Knowledge and preferences of patients with knee and hip osteoarthritis (OA) with respect to total joint arthroplasty (TJA). The European League Against Rheumatism Congress (EULAR), Madrid, Spain 72 (suppl 3), 2013.
129. Suarez-Almazor ME, Kallen MA, Cox V, Street RL. Effect of provider communication style on the improvement of pain and function in patients with knee osteoarthritis. Osteoarthritis Research Society International World Congress on Osteoarthritis, Barcelona, Spain, 2012.
130. Suarez-Almazor ME, Luo R, Nguyen H, Elting L on behalf of CERCIT Inverstigators. Measurement of bone mineral density in patients with breast cancer initiating therapy with aromatase inhibitors (AI):  Low utilization and ethnic disparities. Multinational Association of Supportive Care in Cancer (MASCC) International Symposium, New York City, New York, 2012.
131. Suarez-Almazor ME, Peddi P, Luo R, Nguyen H, Elting L. Low rates of bone mineral density measurement in men with prostate cancer initiating androgen deprivation therapy. Cancer Prevention and Research Institute of Texas Conference, Austin, Texas, 2012.
132. Peddi P, Oh J, Kim K, Gershenwald J, Palla S, Schacherer C, Jakkoju R, Suarez-Almazor ME. Impact of comorbidities on overall survival of high-risk and advanced melanoma. American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2012.
133. Hwang J, Fisch M, Lok A, Zhang H, Vierling J, Suarez-Almazor ME. Trends in hepatitis B virus screening in a large U.S. cancer center. American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2012.
134. Ng B, Petersen N, Yu HJ, Khan M, Suarez-Almazor ME. 10-Year Trends in the Use of Disease Modifying Anti-Rheumatic Drugs (DMARDs) and Biologic Agents in Rheumatoid Arthritis: A National Veteran Affairs Study. American College of Rheumatology (ACR) Annual Scientific Meeting, Washington, DC, 2012.
135. Jones CA, Jhangri GS, Suarez-Almazor ME. Factors Influencing Long-Term Recovery of Total Knee Arthroplasty. Arthritis Rheumatol, 2012.
136. Suarez-Almazor M. Changing health behaviors with social marketing. The European League Against Rheumatism Congress (EULAR), Berlin, Germany 71 (suppl 3):19, 2012.
137. Marengo M, Kallen M, de Achaval S, Cox V, Garcia A, Richardson M, Suarez-Almazor ME. Impact of health literacy on treatment adherence and clinical outcomes in patients with systemic lupus erythematosus. American College of Rheumatology Annual Scientific Meeting, Chicago, IL, 2011.
138. Hwang J, Fisch M, Zhang H, Kallen M, Routbort M, Lal L, Vierling J, Suarez-Almazor M. Reactivation of hepatitis B infection among patients with cancer. Multinational Association of Supportive Care in Cancer (MASCC) International Symposium, Athens, Greece, 2011.
139. Hwang J, Fisch M, Zhang H, Kallen M, Routbort M, Lal L, Vierling J, Suarez-Almazor M. Predictors of Hepatitis B screening among patients with cancer. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA, 2011.
140. Hwang J, Fisch M, Zhang H, Kallen M, Routbort M, Lal L, Vierling J, Suarez-Almazor M. Reactivation of hepatitis B infection among patients with cancer. American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, IL, 2011.
141. Suarez-Almazor M, Roundtree AK, Giralt S. A qualitative study of late effects and healthcare needs of survivors of stem cell transplantation. Multinational Association of Supportive Care in Cancer (MASCC) International Symposium, Athens, Greece, 2011.
142. Suarez-Almazor, ME. Measurement of bone mineral density in patients with breast cancer initiating therapy with aromatase inhibitors: Low utilization and ethnic disparities. Cancer Prevention and Research Institute of Texas Conference, Austin, Texas, 2011.
143. de Achaval S, Fraenkel L, Cox V, Volk R, Suarez-Almazor ME. Effects of decision aids on decisional conflict associated with osteoarthritis treatment. 33rd Annual Meeting of the Society for Medical Decision Making. Chicago, IL, 2011.
144. Waimann C, Fernandez-Mazarambroz R, Cantor S, Lopez-Olivo M, Zhang H, Landon G, Siff SJ, Suarez-Almazor ME. Impact of psychosocial determinants on total knee replacement costs: Results from the patient expectations about knee surgery cohort. American College of Rheumatology (ACR) Annual Scientific Meeting, Chicago, IL, 2011.
145. Waimann C, Fernandez-Mazarambroz R, Cantor S, Lopez-Olivo M, Zhang H, Landon G, Siff SJ, Suarez-Almazor ME. Impact of slow recovery and poor functional outcomes on direct and indirect costs after total knee replacement in osteoarthritis patients. American College of Rheumatology (ACR) Annual Scientific Meeting, Chicago, IL, 2011.
146. Waimann C, Olejeme K, Tayar J, Lei X, Suarez-Almazor ME. Cancer associated myositis: Temporal relationship, survival and risk of cancer recurrence. Results from a large historical cohort in United States of America. American College of Rheumatology (ACR) Annual Scientific Meeting, Chicago, IL, 2011.
147. Jones A, Beaupre L, Jhangri G, Suarez-Almazor ME. Identifying comorbid conditions that affect the 6-month recovery pattern of total knee arthroplasty. American College of Rheumatology (ACR) Annual Scientific Meeting, Chicago, IL, 2011.
148. Lo G, Cox V, Street R, Suarez-Almazor ME. Self-efficacy status is associated with pain, partially mediating the effect of communication style in acupuncture treatment for knee osteoarthritis. American College of Rheumatology (ACR) Annual Scientific Meeting, Chicago, IL, 2011.
149. Marengo M, Kallen M, de Achaval S, Cox V, Garcia A, Richardson M, Suarez-Almazor ME. Impact of health literacy on treatment adherence and clinical outcomes in patients with rheumatoid arthritis (RA). American College of Rheumatology (ACR) Annual Scientific Meeting, Chicago, IL, 2011.
150. Escalante CP, Manzullo E, Rodriguez S, de Achaval S, Novy DM, Suarez-Almazor ME. Collaborative group clinics (CGCs) for cancer-related fatigue. Cancer Prevention and Research Institute of Texas Conference, Austin, TX, 2011.
151. Marengo M, Street RL, de Achaval S, Zhang H, Richardson M, Suarez-Almazor ME. The effect of physician communication on treatment adherence in patients with rheumatoid arthritis (RA). American College of Rheumatology (ACR) Annual Scientific Meeting, Chicago, IL, 2011.
152. Hwang J, Fisch M, Zhang H, Kallen M, Routbort M, Lal L, Vierling J, Suarez-Almazor ME. Low rates of hepatitis B virus screening at the onset of chemotherapy. Cancer Prevention and Research Institute of Texas Conference, Austin, TX, 2011.
153. Lopez-Olivo MA, Martinez-Lopez JA, Tayar JH, Polo Cueto J, Pollono EN, Gonzales-Crespo M, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with bBiologic therapy: Meta-analysis of controlled trials. American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Scientific Meeting, Atlanta, GA, 2010.
154. De Achaval S, Kallen M, Street R, Richardson M, Garcia Gonzalez A, Suarez-Almazor M. Do Patient-Physician relationship components and overall physician trust influence treatment adherence in patients with theumatic disease?. The European League Against Rheumatism Congress (EULAR), Rome, Italy 69 (suppl 3):716, 2010.
155. De Achaval S, Kallen M, Cox V, Richardson M, Suarez-Almazor M. Appointment-eeping in patients with systemic lupus erythematosus. The European League Against Rheumatism Congress (EULAR), Rome, Italy 69 (suppl 3):716, 2010.
156. Lopez-Olivo MA, Tayar JH, Suarez-Almazor ME. Febuxostat for the treatment of chronic recurrent gout: A meta-analysis. The European League Against Rheumatism Congress (EULAR), Rome, Italy 69 (suppl 3):608, 2010.
157. Lopez-Olivo MA, Suarez-Almazor ME, Shaw Y. A Systemic Review to Appraise the Quality of Cost-Effectiveness Studies of Bilogic Agents for the Treatment of Rheumatoid Arthritis. The European League Against Rheumatism Congress (EULAR) , Rome, Italy, 2010.
158. Waimann CA, Marengo MF, de Achaval S, Cox VL, Garcia Gonzalez A, Richardson MN, Suarez-Almazor ME. Measuring therapeutic adherence in rheumatoid arthritis (RA) Using a medication event monitoring system (MEMS®). American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Scientific Meeting, Atlanta, GA, 2010.
159. Marengo MF, Waimann CA, De Achaval S, Cox VL, Garcia Gonzalez A, Richardson MN, Suarez-Almazor ME. Measuring therapeutic adherence in systemic lupus erythematosus (SLE) using the medication event monitoring system (MEMS®). American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Scientific Meeting, Atlanta, GA, 2010.
160. Lopez-Olivo MA, Kallen MA, Pak CH, Siff SJ, Landon GC, Edelstein D, Robinson KC, Suarez-Almazor ME. Using the patient generated index (PGI) to measure personalized quality of life (QoL) in patients undergoing total knee arthroplasty (TKA). American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Scientific Meeting, Atlanta, GA, 2010.
161. Lopez-Olivo MA, Shaw Y, Suarez-Almazor ME. A systematic review to appraise the quality of cost-effectiveness studies of biologic agents for the treatment of rheumatoid arthritis. American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP)Scientific Meeting, Atlanta, GA, 2010.
162. De Achaval S, Kallen MA, Cox VL, Richardson MN, Suarez-Almazor ME. The impact of patient-physician relationship components on physician trust and treatment adherence in patients with rheumatic disease. American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Scientific Meeting, Atlanta, GA, 2010.
163. Rizvi TJ, Gomez J, De Achaval S, Kallen MA, Cox VL, Richardson MN, Ng B, Reveille JD, Suarez-Almazor ME. The impact of health beliefs on therapeutic adherence in patients with rheumatoid arthritis (RA). American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Scientific Meeting, Atlanta, GA, 2010.
164. Beg SA, De Achaval S, Kallen MA, Cox VL, Richardson MN, Reveille JD, Suarez-Almazor ME. Determinants of treatment adherence in patients with systemic lupus erythematosus (SLE). American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Scientific Meeting, Atlanta, GA, 2010.
165. Marengo MF, Waimann CA, Lopez-Olivo MA, Looney C, Suarez-Almazor ME. Controversies in the use of acupuncture for osteoarthritis (OA). A systematic review of the quality and treatment features of randomized clinical trials (RCT). American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP)Scientific Meeting, Atlanta, GA, 2010.
166. Hwang JP, Fisch M, Zhang H, Kallen MA, Vierling J, Suarez-Almazor ME. Hepatitis B screening and positivity prior to chemotherapy. Multinational Association of Supportive Care in Cancer (MASCC) International Symposium, Vancouver, British Columbia, 2010.
167. Hwang JP, Fisch M, Zhang H, Kallen MA, Routbort M, Lal L, Vierling J, Suarez-Almazor ME. Hepatitis B screening and positivity prior to chemotherapy. American Society of Clinical Oncology (ASCO), Chicago, IL, 2010.
168. Holmes H, Bain K, Luo R, Bruera E, Suarez-Almazor M. Use of statins in patients with cancer in hospice care. Multinational Association of Supportive Care in Cancer (MASCC) International Symposium, Vancouver, British Columbia, 2010.
169. Olejeme K, Suarez-Almazor M, Gladish GW, Lei X, Escalante CP. Prevalence of unsuspected venous thromboembolism (VTE) on routine computed tomography (CT) scans in cancer patients. J Clin Oncol 28(2010):(suppl; abstr e19513), 2010.
170. Naqvi K, Suarez-Almazor ME, Sardesai S, Oh J, Vigil C, Pierce S, Lei X, Shan J, Kantarjian H, Garcia-Manero G. Comorbidities and overall survival in myleodysplastic syndromes (MDS): Development of a prognostic model incorporating IPSS and age with ACE-27 comorbidity index. American Society of Hematology, Orlando, FL, 2010.
171. Lopez-Olivo MA, Suarez-Almazor ME, Shaw Y. A systematic review to appraise the quality of cost-effectiveness studies of biologic agents for the treatment of rheumatoid arthritis. The European League Against Rheumatism Congress (EULAR), Rome, Italy 69 (suppl 3):642, 2010.
172. Naqvi K, Garcia-Manero G, Sardesai S, Oh J, Pierce S, Lei X, Suarez-Almazor ME. Comorbidities and myelodysplatic syndromes. 51st American Society of Hematology Annual Meeting and Exposition, New Orleans, LA, 2009.
173. de Achaval S, Kallen MA, Cox V, Mayes M, Suarez-Almazor M. HRQoL domain coverage of the patient generated index in patients with systemic sclerosis: An application of the PROMIS Framework. American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Conference, Philadelphia, Pennsylvania, 2009.
174. Jones CA, Beaupre LA, Jhangri GS, Suarez-Almazor ME. The effect of diabetes over the 6 month recovery after total Knee arthroplasty. American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Conference, Philadelphia, Pennsylvania, 2009.
175. Lopez-Olivo M, Kallen M, Pak C, Siff SJ, Landon GC, Edelstein D, Robinson KC, Zhang HZ, Suarez-Almazor ME. Psychosocial and educational barriers to surgical success after knee athroplasty. American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Conference, Philadelphia, Pennsylvania, 2009.
176. Naqvi K, Oh J, Garcia-Manero G, Pierce S, Suarez-Almazor ME. Comorbidities and prognosis of myelodysplastic syndromes. J Clin Oncol 27(15s):2009 (suppl; abstr 7086), 2009.
177. Lopez-Olivo MA, Kallen MA, Pak C, Siff SJ, Landon GC, Edelstein D, Suarez-Almazor ME. Change of individual values among persons with total knee arthroplasty during the first six months of recovery. OMERACT 9 Conference, Kananaskis, Canada, 2008.
178. Roundtree A, Price AJ, Giordano S, Looney C, Suarez-Almazor ME. Healthcare and information needs in breast cancer survivors: A focus group Study. Division of Internal Medicine Research Retreat, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2008.
179. de Achaval S, Kallen MA, Siff SJ, Landon GC, Edelstein DW, Smith RB, Pak CH, Cox V, Suarez-Almazor ME. Determinants of patients’ expectations about total knee replacement outcomes. American College of Rheumatology (ACR) Annual Scientific Meeting 2008, San Francisco, CA, 2008.
180. Jones CA, Beaupre LA, Midodzi W, Suarez-Almazor ME. Functional implication of comorbidities during recovery of total joint arthroplasties. American College of Rheumatology (ACR) Annual Scientific Meeting 2008, San Francisco, CA, 2008.
181. Jones CA, Suarez-Almazor ME, Cox VC. Delineating the impact of obesity and its relationship with heart disease and diabetes on recovery after total joint arthroplasties. American College of Rheumatology (ACR) Annual Scientific Meeting 2008, San Francisco, CA, 2008.
182. Suarez-Almazor ME, Roundtree AK, Kallen MA, Lopez-Olivo MA, Ortiz Z, Skidmore B. Systematic review of reviews on the use of biologics from rheumatoid arthritis. American College of Rheumatology Annual Scientific Meeting 2007, Boston, MA, 2007.
183. Suarez-Almazor ME, Jones A. Patient satisfaction with total joint replacement. The European League Against Rheumatism Congress (EULAR), Barcelona, Spain 66 (suppl II):511, 2007.
184. Lopez-Olivo MA, Suarez-Almazor ME, Moffett ML. Economic evaluation of biologic therapies in ankylosing spondylitis: A systematic review. The European League Against Rheumatism Congress (EULAR) , Barcelona, Spain 66 (suppl II):274, 2007.
185. Gossec L, Jordan JM, Lam M, Suarez-Almazor ME, Mazzuca S, Renner JB, Lopez-Olivo MA, Hawker G, Dougados M, Maillefert J. Measurement of joint space width appears to be the most valid indicator of structural damage in knee osteoarthritis: a comparative study of 3 radiographic scores in 1759 x-rays. The European League Against Rheumatism Congress (EULAR) , Barcelona, Spain 66 (suppl II):58, 2007.
186. Lopez-Olivo MA, Roundtree AK, Ortiz Z, Skidmore B, Suarez-Almazor ME. Switching between anti-tnf agents treatments for rheumatoid arthritis: a systematic review. The European League Against Rheumatism Congress (EULAR), Barcelona, Spain 66 (suppl II):189, 2007.
187. Suarez-Almazor ME, Lopez-Olivo MA, Pak C, Ortiz Z, Cox VL, Skidmore B. Long-term effectiveness during infliximab or etanercept therapy: a systematic review of observational studies. The European League Against Rheumatism Congress (EULAR) , Barcelona, Spain 66 (suppl II):601, 2007.
188. Lopez-Olivo MA, Kallen MA, Ortiz Z, Roundtree AK, Skidmore B, Suarez-Almazor ME. Scientific validity of clinical practice guidelines for the use of Imnfliximab and etanercept in rheumatoid arthritis. Health Technology Assessment International, Barcelona, Spain, 2007.
189. Suarez-Almazor ME, Roundtree AK, Kallen MA, Lopez-Olivo MA, Ortiz Z, Skidmore B. Systematic review of reviews on the use of biologics from rheumatoid arthritis. Health Technology Assessment International 2007, Barcelona, Spain, 2007.
190. Lopez-Olivo MA, Kallen MA, Pak C, Siff SJ, Landon GC, Eldestein D, Suarez-Almazor ME. Role of social support and depression on pain and function in patients undergoing total knee arthroplasty (TKA). American College of Rheumatology (ACR) Annual Scientific Meeting 2007, Boston, MA, 2007.
191. Lopez-Olivo MA, Kallen MA, Ortiz Z, Roundtree AK, Skidmore B, Suarez-Almazor ME. Scientific validity of clinical practice guidelines for the use of Imnfliximab and Etanercept in rheumatoid arthritis. American College of Rheumatology (ACR) Annual Scientific Meeting 2007, Boston, MA, 2007.
192. Lopez-Olivo MA, Andrabi TR, Suarez-Almazor ME. Cervical spine instability in patient with rheumatoid arthritis (RA) undergoing general surgery. American College of Rheumatology (ACR) Annual Scientific Meeting, Boston, MA, 2007.
193. Lopez-Olivo MA, Kallen MA, Richardson MN, Garcia-Gonzalez A, Cox VL, Lidsky M, Ng B, Marcus DM, Reveille JD, Suarez-Almazor ME. Treatment adherence and use of reminders in patients with rheumatic disease. American College of Rheumatology (ACR) Annual Scientific Meeting 2007, Boston, MA, 2007.
194. Lopez-Olivo MA, Kallen MA, Richardson MN, Garcia-Gonzalez A, Cox VL, Lidsky M, Ng B, Marcus DM, Suarez-Almazor ME, Reveille JD. Effect of depression and social support on the self-reported adherence in patients with rheumatic diseases. American College of Rheumatology (ACR) Annual Scientific Meeting 2007, Boston, MA, 2007.
195. Suarez-Almazor ME, Looney C, Street Jr RL, Liu Yangfang, Cox VL, Pietz K, Marcus DM. A randomized controlled trial of acupuncture for osteoarthritis of the knee: effects of provider communication style. American College of Rheumatology (ACR)Annual Scientific Meeting 2007, Boston, MA, 2007.
196. Suarez-Almazor ME, Lopez-Olivo MA, Pak C, Skidmore B. Long-term effectiveness during infliximab or etanercept therapy: a systematic review of observational studies. American College of Rheumatology (ACR) Annual Scientific Meeting, Boston, MA, 2007.
197. Suarez-Almazor ME, Kriseman YL, Kallen MA, de Achaval S, Mayes MD. Impact of illness and symptom burden in patients with systemic sclerosis. University of Texas Research Day, Houston, TX, 2007.
198. Hawker G, French MR, Cibere J, Jordan JM, Davis AM, March L, Suarez-Almazor M, Dieppe P. Preliminary psychometric testing of a new osteoarthritis pain Measure. American College of Rheumatology (ACR) Annual Scientific Meeting, Boston, MA, 2007.
199. Hawker GA, Stewart L, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Dieppe P. Understanding the pain experience in hip and knee OA. American College of Rheumatology (ACR) Annual Scientific Meeting 2007, Boston, MA, 2007.
200. Giordano TP, Gifford AL, Backus LI, Mole LA, Hartman C, White AC, Suarez-Almazor ME, Rabeneck L, Morgan RO. Comorbidities and retention in HIV care among US veterans. National Institute of Mental Health/International Association of Physicians in AIDS Care International Conference on HIV Treatment Adherence, Jersey City, NJ, 2006.
201. Suarez-Almazor ME, Kriseman Y, Kallen M, Mayes M. Impact of illness and symptom burden in patients with systemic Sclerosis. American College of Rheumatology (ACR) Annual Scientific Meeting, Washington DC, 2006.
202. Lopez-Olivo MA, Moffett ML, Cox VL, Richardson MN, Garcia-Gonzalez A, Suarez-Almazor ME. Association of SF-6D health utilities with activity and side effects in patients with systemic lupus erythematosus. American College of Rheumatology Annual Scientific Meeting, Washington DC, 2006.
203. Berrios-Rivera JP, Street Jr RL, Garcia-Gonzalez A, Kallen MA, Richardson MN, Janssen NM, Marcus DM, Reveille JD, Warner NB, Cox VL, Suarez-Almazor ME. Perceptions of their involvement in care in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus. American College of Rheumatology (ACR) Annual Scientific Meeting, Washington DC, 2006.
204. Berrios-Rivera JP, Johnson ML, Huston DP, Suarez-Almazor ME. Disparities in the use of biologic therapies for the treatment of rheumatoid arthritis (RA). American College of Rheumatology (ACR) Annual Scientific Meeting, Washington DC, 2006.
205. Berrios-Rivera JP, Johnson ML, Huston DP, Suarez-Almazor ME. Trends in biologics utilization in a large cohort of patients with rheumatoid arthritis (RA). American College of Rheumatology (ACR) Annual Scientific Meeting, Washington DC, 2006.
206. Garcia-Gonzalez A, Richardson MN, Kallen MA, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Functional health literacy and numeracy in adults with rheumatoid Arthritis (RA) and systemic lupus erythematosus (SLE). American College of Rheumatology (ACR) Annual Scientific Meeting, Washington DC, 2006.
207. Garcia-Gonzalez A, Richardson MN, Roundtree AK, Kallen MA, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Comparison between Patients' and Physicians' perceptions of patient adherence to therapy for rheumatic disease. American College of Rheumatology (ACR) Annual Scientific Meeting (ACR), Washington DC, 2006.
208. Lopez-Olivo MA, Ortiz Z, Pak C, Cox VL, Kimmel B, Roundtree AK, Skidmore B, Suarez-Almazor ME. A meta-analysis on the timing Of therapeutic introduction of infliximab and etanercept. American College of Rheumatology Annual Scientific Meeting, Washington DC, 2006.
209. Lopez-Olivo MA, Moffett ML, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Economic evaluation of infliximab and etanercept: A systematic review. American College of Rheumatology (ACR) Annual Scientific Meeting, Washington DC, 2006.
210. Lopez-Olivo MA, Garcia-Gonzalez A, Kallen MA, Richardson MN, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Social support and quality of life in patients with rheumatoid Arthritis (RA) and systemic lupus erythematosus (SLE). American College of Rheumatology (ACR) Annual Scientific Meeting, Washington DC, 2006.
211. Lopez-Olivo M, Ortiz Z, Pak CH, Cox V, Kimmel B, Jendall-Roundtree A, Skidmore B, Suarez-Almazor ME. A meta-analysis on the timing of therapeutic introduction of infliximab (IFX) and etanercept (ETN). The European League Against Rheumatism Congress (EULAR), Amsterdam, Netherlands, 2006 65 (suppl II):329, 2006.
212. Berrios-Rivera JP, Johnson ML, Huston DP, Suarez-Almazor ME. Disparities in the use of biologic therapies for the treatment of rheumatoid arthritis (RA). The European League Against Rheumatism Congress (EULAR), Amsterdam, Netherlands 65 (suppl II):275, 2006.
213. Suarez-Almazor ME, Lopez-Olivo M, Kendall-Roundtree A, Ortiz Z, Skidmore B. Dose escalation in anti-TNF therapy for rheumatoid arthritis (RA): a systematic review. The European League Against Rheumatism Congress (EULAR), Amsterdam, Netherlands 65 (suppl II):603, 2006.
214. Lopez-Olivo, Moffett MM, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Economic evaluation of infliximab and etanercept: a systematic review. The European League Against Rheumatism Congress (EULAR), Amsterdam, Netherlands 65 (suppl II):329, 2006.
215. Berrios-Rivera JP, Johnson ML, Huston DP, Suarez-Almazor ME. Trends in biologics utilization in a large cohort of RA patients. The European League Against Rheumatism Congress (EULAR), Amsterdam, Netherlands 65 (suppl II):177, 2006.
216. Garcia-Gonzalez A, Richardson M, Kallen M, Janssen N, Marcus D, Reveille JD, Warner N, Suarez-Almazor M. Principales motives de olvido para tomar tratamiento en tres diferentes grupos etnicos en pacientes con enfermedades reumaticas. XXXIII Congreso Mexicano De Reumatologia, Mexico, 2005.
217. Byrne MM, Souchek J, Richardson M, Suarez-Almazor ME. Ethnic differences in willingness to pay for improvements in osteoarthritis among patients with osteoarthritis. 27th Annual Meeting of the Society for Medical Decision Making, San Francisco, CA, 2005.
218. Byrne MM, Souchek J, Richardson M, Suarez-Almazor ME. Inconsistencies between visual analog scale rankings and willingness to pay for own health and hypothetical scenarios. 27th Annual Meeting of the Society for Medical Decision Making, San Francisco, CA, 2005.
219. Byrne MM, Souchek J, Richardson M, Suarez-Almazor ME. Conjoint analysis of preferences for knee surgery among three racial/ethnic groups. 27th Annual Meeting of the Society for Medical Decision Making, San Francisco, CA, 2005.
220. Garcia-Gonzalez A, Gonzalez-Lopez L, Gamez-Nava JI, Rodriguez-Arreola BE, Cox V, Kallen M, Suarez-Almazor M. Physician-patient communication during the medical interaction in Mexican patients with rheumatic diseases. American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Scientific Meeting, San Diego, CA, 2005.
221. Garcia-Gonzalez A, Richardson M, Popa-Lisseanu MG, Kallen M, Janssen N, Marcus D, Reveille JD, Warner N, Cox V, Suarez-Almazor ME. Treatment adherence in ethnically diverse patients with rheumatoid arthritis and systemic lupus erythematosus (SLE). American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, San Diego, CA, 2005.
222. Berrios-Rivera JP, Garcia Popa-Lisseanu MG, Street Jr RL, Kallen M, Richardson M, Janssen N, Marcus D, Reveille JD, Warner N, Suarez-Almazor ME. Trust in Physicians and its association with characteristics of the medical encounter in patients with rheumatic disease. The European League Against Rheumatism Congress (EULAR), Vienna, Austria 64 (suppl III):391, 2005.
223. Garcia-Gonzalez A, Richardson M, Kallen M, Popa-Lisseanu MG, Janssen N, Marcus D, Reveille JD, Warner N, Cox V, Suarez-Almazor M. Treatment adherence in ethnically diverse patients with rheumatoid arthritis and systemic lupus erythematosus (SLE). Annual Health Services & Outcomes Research Conference, Houston, TX, 2004.
224. Suarez-Almazor M, Haidet P, Gordon H, Street RL. Improving doctor-patient communication. US Department of Veterans Affairs, HSR&D Service Annual Meeting Washington DC, 2004.
225. Suarez-Almazor M, Richardson M, Kelly PA, Byrne M, Souchek J. Ethnic variations in preference for total knee replacement in patients with osteoarthritis. International Society for Pharmacoeconomics and Outcomes Research, Arlington, VA, 2004.
226. Suarez-Almazor M, Souchek J, Kelly PA, Byrne M, Richardson M, Pak C. Ethnic variations in preference for total knee replacement in patients with osteoarthritis. Society of Medical Decision Making 9th Biennial Meeting, Rotterdam, the Netherlands, 2004.
227. Suarez-Almazor M, Greisinger A, Richardson M, Popa-Lisseanu M, O'Malley K, Janssen N, Marcus D, Tagore J. Determinants of treatment adherence in patients with rheumatic disease. Annual European Congress of Rheumatology (EULAR), Berlin, Germany, 2004.
228. Chiou C, Weisman M, Sherbourne C, Reyes C, Dylan M, Ofman J, Wallace DJ, Mizutani W, Suarez-Almazor ME. Measuring preference weights for health states of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases at Annual European Congress of Rheumatology (EULAR), Berlin, Germany, 2004, 2004.
229. Suarez-Almazor M, Blanco A, Kallen M, Reveille JD, Mayes M. Disease and symptom burden in systemic sclerosis - the patients' perspective. American College of Rheumatology (ACR) Annual Scientific Meeting, San Antonio, TX, 2004.
230. Suarez-Almazor ME, Souchek J, Byrne M, Kelly PA, Richardson M, Chong P, Nelson, H. Prospect theory in the valuation of arthritis health states. Annual Meeting of the Society for Medical Decision Making, Atlanta, GA, 2004.
231. Berrios-Rivera JP, Suarez-Almazor M, Kallen M, Richardson M, Janssen N, Marcus D, Street R. Physician-patient communication during the medical interaction with patients with rheumatic disease. 5th Annual Health Services & Outcomes Research Conference, Houston, TX, 2004.
232. Suarez-Almazor M, Byrne MM, O'Malley K. Factors affecting willingness to pay per quality-adjusted life year. Society for Medical Decision Making, Chicago, IL, 2003.
233. Suarez-Almazor M, Richardson M, Sharf B, Kroll T. Determinants of decision-making processes for total knee arthroplasty in patients with osteoarthritis - A Qualitative Analysis. Society for Medical Decision Making, Chicago, IL, 2003.
234. Suarez-Almazor ME. Test-retest reliability of conjoint Analysis. The International Society for Technology Assessment in Health Care, Canada, 2003.
235. O'Malley KJ, Souchek J, Byrne M, Suarez-Almazor M. The joint-specific multidimensional assessment of pain (J-MAP): Comparison with the WOMAC. American College of Rheumatology (ACR) Annual Scientific Meeting, Orlando, FL, 2003.
236. Suarez-Almazor M, Kelly PA, Byrne M, Richardson M, Souchek J. Test-retest reliability of preferences for total knee replacement using conjoint pairs. American College of Rheumatology (ACR) Annual Scientific Meeting, Orlando, FL, 2003.
237. Byrne MM, O’Malley K, Souchek J, Suarez-Almazor M. Purchasing health improvements: Just another consumer good?. Association for Health Services Research Annual Meeting, Washington DC, 2002.
238. Byrne MM, O’Malley K, Suarez-Almazor M. Racial differences for improvements in knee osteoarthritis. Association for Health Services Research Annual Meeting, Washington DC, 2002.
239. Collins TC, Petersen NJ, Suarez-Almazor M. The prevalence of intermittent claudication in an ethnically diverse population. Department of Veterans Affairs Twenty Annual Health Services Research and Development (HSR&D) Meeting, Washington, DC, 2002.
240. Collins TC, Petersen NJ, Suarez-Almazor M, Ashton, CM. Risk factors for peripheral arterial disease in an ethnically diverse population. Society of General Internal Medicine, 25th Annual Meeting, Atlanta, GA, 2002.
241. Byrne M, O’Malley K, Suarez-Almazor ME. Ethnic differences in arthritis health preferences: Analysis using willingness-to-pay. American College of Rheumatology (ACR) Annual Scientific Meeting, New Orleans, LA, 2002.
242. Suarez-Almazor ME, Byrne M, Souchek J, O’Malley K, Richardson M. Valuation of arthritis health states across ethnic groups. American College of Rheumatology (ACR) Annual Scientific Meeting, New Orleans, LA, 2002.
243. Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA. Meta-analysis of the shared epitope and severity of rheumatoid arthritis (RA). Arthritis Rheum 44:S102, 2001.
244. Suarez-Almazor ME, Ahn C, Friedman AW, Fischback MC, McNearney T, Reveille JD. Working status in patients with early systemic sclerosis (SSc). Arthritis Rheum 44:S188, 2001.
245. Suarez-Almazor ME, Conner-Spady B, Kuebeler M. Impact of knowledge of arthritis diagnosis on the utility ratings of functional states. Arthritis Rheum 44:S312, 2001.
246. Manathip O, Shea B, Suarez-Almazor ME, Strand V, Wells G, Tugwell P. Leflunomide for the treatment of rheumatoid arthritis: A systematic review and meta-analysis. Arthritis Rheum 44:S316, 2001.
247. Suarez-Almazor ME, Foster W, Marcus DM, Janssen NM, Sessoms S. Onset of disease-modifying antirrheumatic drug (DMARD) treatment in minority and disadvantaged patients with rheumatoid arthritis (RA). Arthritis Rheum 44:S319, 2001.
248. Conner-Spady, B, Voaklander, D., Suarez-Almazor, M. Error of measurement and the interpretation of change scores in health-related quality of life. Statistics and Health Conference, Edmonton, Canada, 2000.
249. Conner-Spady, B. Voaklander, D., & Suarez-Almazor, M. Calculating QALYs gained: Different methods give different results. Statistics and Health Conference, Edmonton, Canada, 2000.
250. Suarez-Almazor ME, Conner-Spady B, Wristers K, Byrne M. Test-retest reliability of selected utility measures in the rating of arthritis health states. Arthritis Rheum 43:S110, 2000.
251. Suarez-Almazor ME, Conner-Spady B. Rating of arthritis health states by patients, physicians and the public. Implications for cost-utility analyses. Arthritis Rheum 43:S110, 2000.
252. Suarez-Almazor ME, Conner-Spady B. Preference-based classification systems for the assessment of health-related quality of life (HRQL) in patients with musculoskeletal disease. Arthritis Rheum 43:S135, 2000.
253. Suarez-Almazor ME, de Geus C, Homik J, Russell AS. Failure to assess or manage osteoporosis (OP) following a hip fracture (HF). Arthritis Rheum 43:S203, 2000.
254. Cree MW, Carriere KC, Soskolne CL, Suarez-Almazor ME. Function Following Hip Fracture. Arthritis Rheum 43:S286, 2000.
255. Suarez-Almazor ME, Ahn C, Friedman AW, Fischbach MC, McNearney T, Lisse J, Reveille JD. Performance of outcome measures in systemic sclerosis (SSc). Arthritis Rheum 43:S319, 2000.
256. Maksymowych WP, Cooper BL, Tao S, Suarez-Almazor ME, Russell Edmonton AS. Interleukin 1-4, and TNF Alpha cytokine gene polymorphisms in palindromic rheumatism: No association with susceptibility or progression to rheumatoid arthritis. Arthritis Rheum 43:S327, 2000.
257. Carrier ME, Kwakkenbos L, Nielson WR, Fedoruk C, Nielsen K, Milette K, Pope J, Frech T, Gholizadeh S, Hummers L, Johnson SR, Piotrowski P, Jewett L, Gordon J, Chung L, Bilsker D, Turner K, Cumin J, Welling J, Fortune C, Leite C, Gottesman K, Sauve M, Rodriguez Reyna TS, Hudson M, Larche M, van Breda W, Suarez-Almazor ME, Bartlett SJ, Malcarne VL, Mayes MD, Boutron I, Mouthon L, Wigley F, Thombs BD, and the SPIN Investigators. Randomized feasibility trial of the scleroderma patient-centered intervention network self-management (SPIN-SELF) program. 6th Systemic Sclerosis World Congress. Prague, Czech Republic.

Book Chapters

1. Edwards BJ, Pang L, Suarez-Almazor ME. The Older Adult Cancer Survivors. In: Handbook of Cancer Survivorship. Demos Medical Publishing (an imprint of Springer Publishing Co, LLC): New York, NY, 2019.
2. Edwards BJ, Pang L, Suarez-Almazor ME. Late-Term Effects of Cancer Therapy on Older Adult Cancer Survivors. In: Handbook of Cancer Survivorship. Demos Medical Publishing (an imprint of Springer Publishing Co, LLC): New York, NY, 2019.
3. Abdel-Wahab N, Alshawa A, Suarez-Almazor ME. Adverse Events in Cancer Immunotherapy. In: Adv Exp Med Biol, 155-174, 2017.
4. Ingleshwar A, Suarez-Almazor ME. Medical Practice Variations in Joint Replacement in Patients with Osteoarthritis. In: Medical Practice Variations. Edited by Stukel T and Johnson A.. Health Services Research Series: Springer US, 2016.
5. Lu HL, Suarez-Almazor M. Rheumatological Emergencies. In: Oncologic Emergencies. Springer, 161-179, 2016.
6. Lopez-Olivo, MA and Suarez-Almazor, ME. Esclerosis sistemica y Epidemiologia. In: Esclerosis sistemica. 1st edition. Olga Lidia Vera-Lastra & Sergio A. Jimenez: Mexico, DF, 2009.
7. Lopez-Olivo, MA and Suarez-Almazor, ME. Evaluciones economicas de los antagonistas del factor de necrosis tumoral alfa en la espondilitis. In: Espondiloartropatias. 1st Edition. Francisco Ramos Niembro & Ruben Burgos-Vargas: Barcelona, Spain, 2008.
8. Suarez-Almazor ME. Repercusion socioeconomica de las enfermedades reumaticas. In: Reumatologia. Editorial Nomos S.A: Colombia, 2006.
9. Garcia-Gonzalez A, Suarez-Almazor ME. Epidemiologia de las vasculitis. In: Vasculitis. Editorial Alfil: Mexico, 2006.
10. Lopez-Olivo MA, Suarez-Almazor ME. Costo-eficacia de la terapia biologica en las enfermedades reumaticas. In: Terapia Biologica en las Enfermedades Reumaticas. 1st edition. Francisco Ramos Niembro, Javier Orozco-Alcala: Mixcoac, Mexico D.F, 413, 2006.
11. Suarez-Almazor ME. Targeting DMARD therapy. In: Antirheumatic Therapy: Actions and Outcomes. Birkhaeuser Verlag Basel/Switzerland: Germany, 2005.
12. Suarez-Almazor ME. Rheumatoid arthritis. In: Evidence-Based Rheumatology. BMJ Publishing Group, BMA House: London, UK, 2004.
13. Emery P, Suarez-Almazor ME. Rheumatoid arthritis. In: Clinical Evidence: The International Source of the Best Available Evidence for Effective Care. BMJ Publishing Group, BMA House: London, UK, 1349-71, 2003.
14. Suarez-Almazor ME, Foster W. Rheumatoid arthritis. In: Clinical Evidence. A compendium of the best available evidence for effective health care (Issue 5). BMJ Publishing Group, BMA House: London, UK, 2001.
15. Suarez-Almazor ME. Rheumatoid arthritis. In: Clinical Evidence. A compendium of the best available evidence for effective health care (Issue 3). BMJ Publishing Group, BMA House: London, UK, 2000.
16. Suarez-Almazor ME, Foster W. Rheumatoid arthritis. In: Clinical Evidence. A compendium of the best available evidence for effective health care (Issue 4). BMJ Publishing Group, BMA House: London, UK, 2000.
17. Emery P, Foster W, Suarez-Almazor M. Rheumatoid arthritis. In: Clin Evid. 7. BMJ Publishing Group, BMA House: London, UK, 1101-21, 1999.
18. Suarez-Almazor ME, Russell AS. Rheumatoid arthritis: an overview. In: A comprehensive guide to new therapeutic approaches of methotrexate in rheumatoid arthritis. PharmaLibri: Morristown, NJ, 1987.

Letters to the Editor

1. Tummala S, Pundole X, Aldrich J, Suarez-Almazor ME. Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors. Arthritis Rheumatol 73: 1564, 2021.